Autosomal Recessive Nonsyndromic Hearing Loss 31

Mendelian MONDO:0011767 Pathograph 11 Show in embeddings browser Nonsyndromic Hearing Loss

DFNB31 is nonsyndromic sensorineural hearing loss caused by biallelic variants in WHRN, which encodes whirlin - a PDZ-domain scaffold protein at the tips of hair-cell stereocilia. It was identified through the whirler mouse, a spontaneous mutant that does not respond to sound and whose hair cells carry abnormally short stereocilia; transgene correction and mutation analysis identified whirlin, and the same gene was shown to underlie the human DFNB31 locus. The mechanism is a failure of stereocilia elongation and bundle organization rather than a defect in the mechanotransduction channel itself. Whirlin sits at the stereocilium tip, the site of actin polymerization, where it forms a complex with EPS8 that sets stereocilium length; its appearance and fade-out across the rows of a growing bundle is graded, and removing it leaves the bundle short and disordered. The transduction apparatus is not the lesion - the structure it needs is. What makes this entry more than a per-locus record is that the same gene also causes Usher syndrome type 2D, and the two are allelic. Clinically they are clearly different: DFNB31 patients have profound hearing loss and normal vision, while USH2D patients have moderate hearing loss with retinitis pigmentosa. WHRN has two major isoforms, a long form encoded by exons 1-13 and a short form from exons 6-13 that lacks the N-terminal PDZ1 and PDZ2 domains. The reported human alleles line up with that split - the DFNB31 alleles fall in the C-terminal half, the USH2D alleles in the long-isoform-specific N terminus - and the proposal that mutations causing Usher syndrome are restricted to the long-isoform-specific exons is the mechanistic account of why one gene gives a syndromic and a non-syndromic disease. It remains a proposal drawn from a small number of clinical reports, not a validated rule, and at least one reported nonsyndromic case carries a missense variant inside the N-terminal region the rule would assign to Usher syndrome. DFNB31 is rare even among recessive nonsyndromic hearing loss. The Tunisian study that reported the second family screened 62 further unrelated ARNSHL families and found no linkage to the locus at all.

Ask OpenScientist

Ask a research question about Autosomal Recessive Nonsyndromic Hearing Loss 31. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
4
Pathophys.
2
Phenotypes
2
Gaps
11
Pathograph
1
Genes
2
Medical Actions
1
Differentials
3
Models
8
References
1
Deep Research
👪

Inheritance

1
Autosomal recessive HP:0000007
Reported as homozygosity in consanguineous Tunisian and Moroccan families and as biallelic C-terminal alleles in the original DFNB31 kindreds.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:15841483 SUPPORT DIRECT Human Clinical
"in a consanguineous Tunisian family segregating congenital profound ARNSHL"
Recessive segregation of the DFNB31 locus in a consanguineous kindred.
PMID:37924449 SUPPORT DIRECT Human Clinical
"Exome sequencing in a consanguineous Moroccan patient with severe hearing loss identified a single homozygous mutation"
Independent homozygous WHRN variant in a second consanguineous family.
?

Discussions and Knowledge Gaps

2
Whirlin-null mice have overt vestibular dysfunction and no published WHRN patient reports a vestibular deficit. Is human DFNB31 genuinely vestibular-sparing, or has vestibular function never been tested?
HUMAN MODEL MISMATCH dfnb31_vestibular_mouse_human_mismatch
Whirlin is expressed in vestibular hair cells as well as cochlear ones, and the same stereocilia machinery builds both bundles, so a vestibular phenotype is what the mechanism predicts. The whirler mouse circles and head-bobs, and the mouse lacking both isoforms has profound deafness with vestibular dysfunction. Against that, the review summarising the published WHRN patients records that none of them self-reported a vestibular deficit - which is a statement about what patients volunteered, not about what testing showed. Whether DFNB31 spares the human vestibular system, or whether the deficit is present and compensated or simply unmeasured, changes what should be offered clinically: vestibular assessment and balance habilitation in a deaf child are not routine unless a deficit is suspected.
Proposed experiments
Formal vestibular testing of a DFNB31 cohort
exp_dfnb31_formal_vestibular_testing
Vestibular-evoked myogenic potentials, caloric testing and video head impulse testing in genotyped DFNB31 patients, with age-matched controls, rather than symptom questionnaires.
Supporting outcome
  • Measurable vestibular hypofunction in DFNB31 patients would show that the murine phenotype translates and that the absence of self-reported symptoms reflects compensation rather than sparing.
Refuting outcome
  • Normal vestibular function on formal testing would establish a real cochlear-restricted phenotype in humans and make the mouse a poor model for this aspect of the disease.
Show evidence (3 references)
PMID:30831381 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"None of these aforementioned patients self-reported any vestibular deficits."
The human side of the mismatch, and the reason it is weak - self-report, not testing.
PMID:30831381 SUPPORT REVIEW SYNTHESIS Model Organism
"However, both Whrnneo and Whrnwi mice show similar severe to profound loss of linear vestibular evoked potential (VsEP) responses."
On objective testing both mouse alleles lose otolith responses, including the one without overt balance behaviour, so a deficit can be present where behaviour misses it. That is the case for formal testing rather than self-report in patients.
PMID:27117407 SUPPORT DIRECT Model Organism
"Lack of both isoforms causes abnormally short stereocilia and profound deafness and vestibular dysfunction."
The murine side of the mismatch.
Is the 5' / 3' positional rule - long-isoform-specific N-terminal alleles give Usher syndrome type 2D, C-terminal alleles give non-syndromic DFNB31 - actually a rule, or a pattern in a handful of families?
KNOWLEDGE GAP dfnb31_isoform_position_genotype_phenotype_rule
Attached to
The rule is the entry's mechanistic account of why one gene gives two diseases, and it is doing real clinical work: it is what would decide whether a WHRN-positive deaf child is put under retinal surveillance. But it rests on two alleles in one German USH2 family set against the DFNB31 alleles known in 2007, and its authors stated it as a proposal. One later nonsyndromic report carries a homozygous missense change at residue 207, inside the long-isoform-specific region, without a reported retinal assessment. Until a genotype-stratified cohort with ophthalmological follow-up exists, the rule should not be used to withhold retinal surveillance.
Proposed experiments
Genotype-stratified retinal follow-up of WHRN-positive hearing loss
exp_dfnb31_genotype_stratified_retinal_followup
Assemble WHRN biallelic cases from hearing loss cohorts, classify alleles by whether they affect the long-isoform-specific exons, and follow retinal function longitudinally into the third decade.
Would support
Would refute
Supporting outcome
  • Retinitis pigmentosa confined to carriers of long-isoform-specific alleles would turn the proposal into a usable clinical rule.
Refuting outcome
  • Retinal degeneration in carriers of C-terminal alleles, or its absence in carriers of N-terminal ones, would show that isoform position does not determine the syndromic boundary.
Show evidence (1 reference)
PMID:17171570 SUPPORT INDIRECT Human Clinical
"We propose that mutations causing Usher syndrome are probably restricted to exons 1-6 that are specific for the long isoform and probably crucial for retinal function."
The proposal, in the authors' own hedged wording.
⚙

Pathophysiology

4
Biallelic WHRN Loss of Function
Biallelic WHRN variants remove or truncate whirlin, a PDZ-domain scaffold with two N-terminal PDZ domains, a proline-rich region and a C-terminal PDZ. The gene has two major isoforms - a long form encoded by exons 1-13 and a short form from exons 6-13 lacking PDZ1 and PDZ2 - and the alleles reported in DFNB31 sit in the C-terminal half, so both isoforms lose their C-terminal PDZ. The first DFNB31 allele described is the exon 10 nonsense change R778X; a frameshift in exon 11, G808DfsX11, was reported next.
WHRN hgnc:16361 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves WHRN (hgnc:16361). hgnc:16361 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context variant_origin: GERMLINE zygosity: HOMOZYGOUS functional_impact_category: LOSS_OF_FUNCTION
Nonsense and frameshift alleles in the C-terminal half of the protein, reported homozygously in consanguineous families.
Show evidence (2 references)
PMID:12833159 SUPPORT DIRECT Human Clinical
"The gene encoding whirlin also underlies the human autosomal recessive deafness locus DFNB31."
Establishes WHRN as the DFNB31 gene in humans.
PMID:30831381 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"The first WHRN mutation identified in DFNB31 patients is a cysteine to threonine substitution in exon 10, which changes the arginine codon to a stop codon (R778X)"
Names the founding DFNB31 allele and its position in the C-terminal half. Quoted from a review summarising the primary reports rather than from a primary report, hence REVIEW_SYNTHESIS.
Loss of Whirlin from the Stereocilia Tip Complex
Whirlin localizes to the tips of stereocilia, and its expression there is dynamic rather than static: it appears and fades out in an ordered sequence across the rows of the growing bundle, fading from inner hair cells before outer hair cells. At the tip the short isoform binds EPS8, and the pair are required together for normal length regulation. Losing whirlin therefore removes the scaffold that assembles the actin-regulatory machinery at the one place in the stereocilium where the actin core grows.
cochlear hair cell CL:0000202 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear hair cell, annotated with auditory hair cell (CL:0000202). CL:0000202 is a cell type from the Cell Ontology.
stereocilium tip GO:0032426 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves stereocilium tip (GO:0032426). GO:0032426 is a cellular component from the Gene Ontology.
Show evidence (2 references)
PMID:15590699 SUPPORT DIRECT Model Organism
"We show that whirlin localizes at the tips of stereocilia."
Places whirlin at the stereocilium tip, which is where the lesion acts.
PMID:27117407 SUPPORT DIRECT Model Organism
"WHRN-S interacts with EPS8, and both are required at stereocilia tips for normal length regulation."
Identifies the tip complex whose loss produces the short-stereocilia phenotype.
Failure of Stereocilia Elongation and Bundle Organization
Hair bundles in whirlin-null mice are built from abnormally short stereocilia, in both inner and outer hair cells. The defect is in elongation and maintenance of the actin core and in the organization of the bundle, not in the presence of the stereocilia themselves. The isoforms divide the work: a mouse expressing the short isoform but not the long one keeps inner hair cell bundles close to normal and loses outer hair cell bundle morphology, organization and function, so the long isoform is doing something the short one does not - its localization midway along the shorter stereocilia coincides with the inter-stereociliary links.
cochlear hair cell CL:0000202 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear hair cell, annotated with auditory hair cell (CL:0000202). CL:0000202 is a cell type from the Cell Ontology.
stereocilia elongation by actin polymerization GO:0030041 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased stereocilia elongation by actin polymerization, annotated with actin filament polymerization (GO:0030041). GO:0030041 is a biological process from the Gene Ontology. ↓ DECREASED auditory hair cell stereocilium organization GO:0060088 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal auditory hair cell stereocilium organization, annotated with auditory receptor cell stereocilium organization (GO:0060088). GO:0060088 is a biological process from the Gene Ontology. ⚠ ABNORMAL stereocilium maintenance GO:0120045 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased stereocilium maintenance (GO:0120045). GO:0120045 is a biological process from the Gene Ontology. ↓ DECREASED
stereocilium bundle GO:0032421 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves stereocilium bundle (GO:0032421). GO:0032421 is a cellular component from the Gene Ontology.
Show evidence (4 references)
PMID:12833159 SUPPORT DIRECT Model Organism
"detailed ultrastructural analysis of sensory hair cells in the organ of Corti of the inner ear indicates that the whirler gene encodes a protein involved in the elongation and maintenance of stereocilia in both inner hair cells (IHCs) and outer hair cells (OHCs)"
Ultrastructural demonstration that the lesion is one of stereocilia elongation and maintenance.
PMID:12833159 SUPPORT INDIRECT Model Organism
"this novel PDZ domain-containing molecule acts as an organizer of submembranous molecular complexes that control the coordinated actin polymerization and membrane growth of stereocilia"
The authors' mechanistic account of how whirlin controls elongation. Graded INDIRECT because it is offered as a suggestion from the phenotype rather than a measurement.
PMID:27117407 SUPPORT DIRECT Model Organism
"Lack of both isoforms causes abnormally short stereocilia and profound deafness and vestibular dysfunction."
Links complete whirlin loss to short stereocilia and to profound deafness in the mouse.
+ 1 more reference
Hair Bundle Mechanotransduction Failure
With short, disordered bundles the hair cell cannot convert sound-induced deflection into a receptor potential, and the cochlea does not transmit. The transduction machinery itself is not the lesion in DFNB31 - the bundle architecture it depends on is - which is why the deficit is sensorineural and cochlear rather than retrocochlear.
cochlear hair cell CL:0000202 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear hair cell, annotated with auditory hair cell (CL:0000202). CL:0000202 is a cell type from the Cell Ontology.
detection of mechanical stimulus involved in hearing GO:0050910 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased detection of mechanical stimulus involved in hearing, annotated with detection of mechanical stimulus involved in sensory perception of sound (GO:0050910). GO:0050910 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (2 references)
PMID:27117407 SUPPORT INDIRECT Model Organism
"While the Whrnwi/wi mutant is profoundly deaf and exhibits circling and headbobbing behavior, we found that the Whrntm1b mutant shows only moderate to severe hearing loss"
Ties bundle state to auditory outcome across two mouse alleles. INDIRECT for the human claim because the measured outcome is murine auditory function.
PMID:30831381 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
The human endpoint, and the contrast with the allelic syndromic disease.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Autosomal Recessive Nonsyndromic Hearing Loss 31 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

2
Profound Sensorineural Hearing Impairment Auditory HP:0011476 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Profound sensorineural hearing impairment (HP:0011476). HP:0011476 is a phenotype from the Human Phenotype Ontology.
No frequency band is recorded. Profound hearing loss is the ascertainment criterion for every reported DFNB31 family, so any band computed from those reports would restate the inclusion criterion rather than measure penetrance.
Show evidence (2 references)
PMID:30831381 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
States the DFNB31 auditory phenotype and its severity.
PMID:15841483 SUPPORT DIRECT Human Clinical
"in a consanguineous Tunisian family segregating congenital profound ARNSHL"
Primary report of congenital profound loss in a DFNB31-linked family.
Congenital Onset of Hearing Loss Auditory HP:0008527 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital sensorineural hearing impairment (HP:0008527). HP:0008527 is a phenotype from the Human Phenotype Ontology.
Denominator is one family. No frequency band, for the same reason as the phenotype above.
Show evidence (1 reference)
PMID:15841483 SUPPORT DIRECT Human Clinical
"in a consanguineous Tunisian family segregating congenital profound ARNSHL"
The one report that states onset describes it as congenital.
🧬

Genetic Associations

1
WHRN variants (Causative)
Gene: WHRN hgnc:16361 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is WHRN (hgnc:16361). hgnc:16361 is a gene from the HUGO Gene Nomenclature Committee.
Autosomal recessive
Show evidence (3 references)
PMID:17171570 SUPPORT DIRECT Human Clinical
"While mutations in the C-terminal half of whirlin have previously been reported in non-syndromic deafness (DFNB31), both alterations identified in our USH2 family affect the long protein isoform."
States the positional contrast between the DFNB31 and USH2D allele sets.
PMID:17171570 SUPPORT INDIRECT Human Clinical
"We propose that mutations causing Usher syndrome are probably restricted to exons 1-6 that are specific for the long isoform and probably crucial for retinal function."
The genotype-phenotype proposal itself. Graded INDIRECT because the authors offer it as a hypothesis from two alleles in one family plus the prior DFNB31 reports.
PMID:37924449 SUPPORT INDIRECT Human Clinical
"Exome sequencing in a consanguineous Moroccan patient with severe hearing loss identified a single homozygous mutation"
A homozygous WHRN variant at residue 207 - inside the region the positional rule assigns to Usher syndrome - reported in hearing loss. Recorded as a complication of that rule, and graded INDIRECT because the source does not report an ophthalmological assessment that would settle whether the case is syndromic.
💊

Medical Actions

2
Cochlear Implantation
Action: cochlear device implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear device implantation, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Device
The standard intervention for congenital profound sensorineural hearing loss. The mechanism supports it in principle: the lesion is in the hair bundle, upstream of the spiral ganglion an implant stimulates, and no cochlear malformation is described in this disease. No outcome data exist for DFNB31 patients specifically.
Mechanism Target:
BYPASSES Hair Bundle Mechanotransduction Failure — Bypasses the failed transduction step by stimulating the auditory nerve directly.
Early Identification and Habilitation
Action: auditory habilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is auditory habilitation, annotated with Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. Ontology label: Rehabilitation NCIT:C15315
Platform: Behavioral / lifestyle
Where the loss is congenital and profound, the modifiable outcome is spoken-language development and the modifier is how early it is identified and habilitated. Newborn hearing screening detects it.
📊

Prevalence

1
Tunisian families with autosomal recessive nonsyndromic hearing loss
Cases In Literature Not yet documented
No prevalence estimate exists. What is on record is a negative screen: after identifying the second DFNB31 family, the authors typed 62 further unrelated informative Tunisian ARNSHL families and found no linkage to the locus in any of them.
Show evidence (2 references)
PMID:15841483 SUPPORT DIRECT Human Clinical
"we performed linkage analysis in 62 unrelated informative families affected with ARNSHL. No linkage was found to this locus."
The negative linkage screen behind the rarity statement.
PMID:15841483 SUPPORT DIRECT Human Clinical
"we concluded that DFNB31/WHRN is most likely to be a rare cause of ARNSHL in the Tunisian population"
The authors' own rarity conclusion.
🔀

Differential Diagnoses

1

Conditions with similar clinical presentations that must be differentiated from Autosomal Recessive Nonsyndromic Hearing Loss 31:

Usher syndrome type 2D
Overlapping Features The allelic syndromic disease, caused by variants in the same gene. It is the differential that matters here, because the distinction is not made on the audiogram alone: USH2D hearing loss is moderate rather than profound, and the discriminating feature is retinitis pigmentosa, which begins around the second decade. A child with WHRN-related hearing loss and a variant in the long-isoform-specific N terminus is therefore a candidate for retinal surveillance rather than a settled DFNB31 diagnosis.
Show evidence (2 references)
PMID:30831381 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
The clinical discriminator between the two WHRN diseases.
PMID:17171570 SUPPORT DIRECT Human Clinical
"this is the first case of USH2 that is allelic to non-syndromic deafness"
Establishes that the two WHRN diseases are allelic, which is why this differential exists at all.
🐁

Animal Models

3
Whirler mouse (Whrn wi/wi)
The spontaneous mutant through which the gene was found. Whirler mice do not respond to sound and their inner and outer hair cells carry abnormally short stereocilia. Because the deletion removes both major isoforms, the model is the null end of the WHRN allelic series rather than a copy of any particular human allele.
Species
Mouse
Genotype
Whrn wi/wi - spontaneous deletion removing most of exons 6-10, ablating both major whirlin isoforms
Publication
Show evidence (1 reference)
PMID:12833159 SUPPORT Model Organism
"The whirler mouse mutant (wi) does not respond to sound stimuli"
Establishes the model's auditory phenotype.
Whrn tm1b long-isoform-null mouse
The isoform-dissecting model. Retaining the short isoform alone leaves inner hair cell bundles close to normal, damages outer hair cell bundles, and produces moderate to severe rather than profound hearing loss with no overt vestibular dysfunction. It is the experimental basis for the proposal that isoform-specific loss explains the difference between DFNB31 and USH2D.
Species
Mouse
Genotype
Whrn tm1b(KOMP)Wtsi homozygote - exon 4 deleted, expresses WHRN-S but not WHRN-L
Publication
AAV8-whirlin gene transfer in whirler mice
A rescue experiment rather than a disease model: delivering wild-type whirlin cDNA to neonatal whirler cochleas restored normal stereocilia length and bundle architecture in infected hair cells and increased inner hair cell survival relative to the untreated contralateral ear.
Species
Mouse
Genotype
Whrn wi/wi treated with AAV8 carrying wild-type whirlin cDNA by neonatal round-window injection
Publication
Show evidence (1 reference)
PMID:26307667 SUPPORT Model Organism
"Wild-type whirlin cDNA was delivered via adeno-associated virus (AAV8) by injection through the round window of the cochleas in neonatal whirler mice."
Describes the delivery route and construct.
{ }

Source YAML

click to show
name: Autosomal Recessive Nonsyndromic Hearing Loss 31
category: Mendelian
creation_date: "2026-09-16T00:00:00Z"
synonyms:
- DFNB31
- Deafness, autosomal recessive 31
- Autosomal recessive nonsyndromic deafness 31
- WHRN-associated nonsyndromic hearing loss
- Autosomal recessive nonsyndromic deafness caused by mutation in WHRN
description: >-
  DFNB31 is nonsyndromic sensorineural hearing loss caused by biallelic variants in WHRN,
  which encodes whirlin - a PDZ-domain scaffold protein at the tips of hair-cell stereocilia.
  It was identified through the whirler mouse, a spontaneous mutant that does not respond to
  sound and whose hair cells carry abnormally short stereocilia; transgene correction and
  mutation analysis identified whirlin, and the same gene was shown to underlie the human
  DFNB31 locus.

  The mechanism is a failure of stereocilia elongation and bundle organization rather than a
  defect in the mechanotransduction channel itself. Whirlin sits at the stereocilium tip, the
  site of actin polymerization, where it forms a complex with EPS8 that sets stereocilium
  length; its appearance and fade-out across the rows of a growing bundle is graded, and
  removing it leaves the bundle short and disordered. The transduction apparatus is not
  the lesion - the structure it needs is.

  What makes this entry more than a per-locus record is that the same gene also causes Usher
  syndrome type 2D, and the two are allelic. Clinically they are clearly different: DFNB31
  patients have profound hearing loss and normal vision, while USH2D patients have moderate
  hearing loss with retinitis pigmentosa. WHRN has two major isoforms, a long form encoded by
  exons 1-13 and a short form from exons 6-13 that lacks the N-terminal PDZ1 and PDZ2 domains.
  The reported human alleles line up with that split - the DFNB31 alleles fall in the
  C-terminal half, the USH2D alleles in the long-isoform-specific N terminus - and the
  proposal that mutations causing Usher syndrome are restricted to the long-isoform-specific
  exons is the mechanistic account of why one gene gives a syndromic and a non-syndromic
  disease. It remains a proposal drawn from a small number of clinical reports, not a
  validated rule, and at least one reported nonsyndromic case carries a missense variant
  inside the N-terminal region the rule would assign to Usher syndrome.

  DFNB31 is rare even among recessive nonsyndromic hearing loss. The Tunisian study that
  reported the second family screened 62 further unrelated ARNSHL families and found no
  linkage to the locus at all.
disease_term:
  preferred_term: autosomal recessive nonsyndromic hearing loss 31
  term:
    id: MONDO:0011767
    label: autosomal recessive nonsyndromic hearing loss 31
parents:
- Nonsyndromic Hearing Loss
notes: >-
  Identifiers. OMIM #607084 (DFNB31) is the OMIM key for this concept, and WHRN is
  hgnc:16361 at 9q32. They are recorded in prose because the schema's `mappings` block
  carries `mondo_mappings` only and has no slot for an OMIM identifier.

  Scope, and the entity next door. This entry is the non-syndromic disease only. WHRN also
  causes Usher syndrome type 2D, which is curated in `Usher_Syndrome.yaml` as a WHRN
  subtype; the allelic relationship between the two is curated here because it is what
  explains the DFNB31 phenotype, but USH2D itself is not re-curated. The other WHRN
  neighbour in the KB, `Autosomal_Recessive_Nonsyndromic_Hearing_Loss_48`, is a CIB2 entry
  that mentions whirlin only in mechanism prose and argues that CIB2's stereocilia role is
  not exercised through whirlin; it is not coverage of this disease.

  Evidence base and its shape. The human evidence for DFNB31 is thin, and worth stating
  plainly: the founding report (PMID:12833159) names the human locus but is largely a mouse
  paper, the second family (PMID:15841483) is one consanguineous Tunisian kindred, and a
  third (PMID:37924449) is one consanguineous Moroccan patient. The allele list this entry
  quotes - R778X in exon 10, G808DfsX11 in exon 11 - comes from a review (PMID:30831381)
  summarising those primary reports, and is graded `REVIEW_SYNTHESIS` accordingly. No
  frequency bands are recorded on the phenotypes, because with three reported families
  every band would be computed from an ascertainment criterion rather than from a cohort.

  Mechanism evidence is mouse and cell biology throughout, and is graded that way. Whirlin's
  tip localization and its dynamic gradation across stereocilia rows (PMID:15590699), the
  isoform-specific localization and the WHRN-S/EPS8 length-regulation complex
  (PMID:27117407), and the AAV8 rescue (PMID:26307667) are all mouse work. None of it is
  used as the sole support for a human phenotype.

  Two things this entry deliberately does not assert. First, it does not claim that DFNB31
  patients have been shown to have normal retinas by examination. The review states that
  DFNB31 patients have normal vision, and that is recorded as written, but no source read
  here reports a systematic ophthalmological assessment of a DFNB31 cohort. Second, it does
  not resolve vestibular involvement. The whirler mouse circles and head-bobs, and the
  double-isoform-null mouse has overt vestibular dysfunction, while the review records that
  none of the published WHRN patients self-reported a vestibular deficit - self-report, not
  testing. That disagreement is recorded as a HUMAN_MODEL_MISMATCH discussion rather than
  resolved.

  Bilaterality and progression are not curated. Neither "bilateral" nor a progression course
  is described for DFNB31 in the references read here. Recessive cochlear disease is
  bilateral in expectation, but expectation is not a source, so `HP:0008619` is not bound.

  Deep research. A Falcon deep-research report is committed alongside this entry. The query
  was seeded with a disambiguated disease name ("DFNB31 WHRN whirlin-related autosomal
  recessive nonsyndromic hearing loss") rather than the bare numbered locus name, because
  numbered loci are where providers substitute a different disease. It came back on topic:
  `just preflight-dr` passed against MONDO:0011767 with WHRN mentioned 66 times and the
  correct OMIM number (607084) present, and its own reference validation resolved 9 of 9
  citations with a confabulation rate of 0. It was used as a lead source only - every
  snippet in this entry is anchored to a PMID fetched into `references_cache/` and read
  directly - and it did not change any conclusion drawn from the primary literature.

  The report states that the AAV8 rescue restored stereocilia morphology but did **not**
  improve hearing, and that treating adult mice did not restore stereocilia at all. The
  first half is confirmed by the whirlin isoform review (PMID:30831381), which is cached in
  full and is cited on the AAV8 model's readout; the same review reports that posterior
  semicircular canal delivery partially improved hearing and balance, so the negative result
  is route-specific. The adult-treatment claim is attributed to the gene-therapy paper's full
  text, which is not cached (its abstract and DOI record do not contain it), so it is not
  asserted here.
references:
- reference: PMID:12833159
  title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
- reference: PMID:15841483
  title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
- reference: PMID:17171570
  title: "A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss."
- reference: PMID:30831381
  title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
- reference: PMID:15590699
  title: Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium.
- reference: PMID:27117407
  title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
- reference: PMID:26307667
  title: Gene Therapy Restores Hair Cell Stereocilia Morphology in Inner Ears of Deaf Whirler Mice.
- reference: PMID:37924449
  title: Novel pathogenic WHRN variant causing hearing loss in a moroccan family.
inheritance:
- name: Autosomal recessive
  description: >-
    Reported as homozygosity in consanguineous Tunisian and Moroccan families and as
    biallelic C-terminal alleles in the original DFNB31 kindreds.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:15841483
    reference_title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "in a consanguineous Tunisian family segregating congenital profound ARNSHL"
    explanation: Recessive segregation of the DFNB31 locus in a consanguineous kindred.
  - reference: PMID:37924449
    reference_title: Novel pathogenic WHRN variant causing hearing loss in a moroccan family.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing in a consanguineous Moroccan patient with severe hearing loss identified a single homozygous mutation"
    explanation: Independent homozygous WHRN variant in a second consanguineous family.
pathophysiology:
- name: Biallelic WHRN Loss of Function
  description: >-
    Biallelic WHRN variants remove or truncate whirlin, a PDZ-domain scaffold with two
    N-terminal PDZ domains, a proline-rich region and a C-terminal PDZ. The gene has two
    major isoforms - a long form encoded by exons 1-13 and a short form from exons 6-13
    lacking PDZ1 and PDZ2 - and the alleles reported in DFNB31 sit in the C-terminal half,
    so both isoforms lose their C-terminal PDZ. The first DFNB31 allele described is the
    exon 10 nonsense change R778X; a frameshift in exon 11, G808DfsX11, was reported next.
  role: trigger
  biological_scale: MOLECULAR
  genes:
  - preferred_term: WHRN
    term:
      id: hgnc:16361
      label: WHRN
  genetic_context:
    functional_impact_category: LOSS_OF_FUNCTION
    variant_origin: GERMLINE
    zygosity: HOMOZYGOUS
    description: >-
      Nonsense and frameshift alleles in the C-terminal half of the protein, reported
      homozygously in consanguineous families.
  downstream:
  - target: Loss of Whirlin from the Stereocilia Tip Complex
    description: >-
      The truncated protein cannot serve as the tip scaffold; in the whirler mouse, which
      ablates both major isoforms, the tip pool is what is missing.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:12833159
    reference_title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "The gene encoding whirlin also underlies the human autosomal recessive deafness locus DFNB31."
    explanation: Establishes WHRN as the DFNB31 gene in humans.
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: "The first WHRN mutation identified in DFNB31 patients is a cysteine to threonine substitution in exon 10, which changes the arginine codon to a stop codon (R778X)"
    explanation: >-
      Names the founding DFNB31 allele and its position in the C-terminal half. Quoted from
      a review summarising the primary reports rather than from a primary report, hence
      REVIEW_SYNTHESIS.
- name: Loss of Whirlin from the Stereocilia Tip Complex
  description: >-
    Whirlin localizes to the tips of stereocilia, and its expression there is dynamic rather
    than static: it appears and fades out in an ordered sequence across the rows of the
    growing bundle, fading from inner hair cells before outer hair cells. At the tip the
    short isoform binds EPS8, and the pair are required together for normal length
    regulation. Losing whirlin therefore removes the scaffold that assembles the
    actin-regulatory machinery at the one place in the stereocilium where the actin core
    grows.
  biological_scale: MOLECULAR
  cell_types:
  - preferred_term: cochlear hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  cellular_components:
  - preferred_term: stereocilium tip
    term:
      id: GO:0032426
      label: stereocilium tip
  downstream:
  - target: Failure of Stereocilia Elongation and Bundle Organization
    description: >-
      Without the tip scaffold the actin core is not elongated to its programmed length and
      the graded row heights are not established.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:15590699
    reference_title: Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "We show that whirlin localizes at the tips of stereocilia."
    explanation: Places whirlin at the stereocilium tip, which is where the lesion acts.
  - reference: PMID:27117407
    reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "WHRN-S interacts with EPS8, and both are required at stereocilia tips for normal length regulation."
    explanation: Identifies the tip complex whose loss produces the short-stereocilia phenotype.
- name: Failure of Stereocilia Elongation and Bundle Organization
  description: >-
    Hair bundles in whirlin-null mice are built from abnormally short stereocilia, in both
    inner and outer hair cells. The defect is in elongation and maintenance of the actin
    core and in the organization of the bundle, not in the presence of the stereocilia
    themselves. The isoforms divide the work: a mouse expressing the short isoform but not
    the long one keeps inner hair cell bundles close to normal and loses outer hair cell
    bundle morphology, organization and function, so the long isoform is doing something
    the short one does not - its localization midway along the shorter stereocilia
    coincides with the inter-stereociliary links.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: cochlear hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  cellular_components:
  - preferred_term: stereocilium bundle
    term:
      id: GO:0032421
      label: stereocilium bundle
  biological_processes:
  - preferred_term: stereocilia elongation by actin polymerization
    modifier: DECREASED
    term:
      id: GO:0030041
      label: actin filament polymerization
  - preferred_term: auditory hair cell stereocilium organization
    modifier: ABNORMAL
    term:
      id: GO:0060088
      label: auditory receptor cell stereocilium organization
  - preferred_term: stereocilium maintenance
    modifier: DECREASED
    term:
      id: GO:0120045
      label: stereocilium maintenance
  downstream:
  - target: Hair Bundle Mechanotransduction Failure
    description: >-
      A bundle of short, ungraded stereocilia cannot deflect and gate as a bundle of graded
      ones does, so sound no longer produces a normal receptor response.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - loss of graded stereocilia row heights
    - loss of the inter-stereociliary link geometry that couples the rows, so tip-link
      tension is not developed normally on deflection
  - target: Congenital Onset of Hearing Loss
    description: >-
      The bundle defect is developmental - the stereocilia never reach their programmed
      length - so the deficit is present from birth rather than acquired, which is how the
      one family with a reported onset is described.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - failure of hair bundle maturation during cochlear development
  evidence:
  - reference: PMID:12833159
    reference_title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "detailed ultrastructural analysis of sensory hair cells in the organ of Corti of the inner ear indicates that the whirler gene encodes a protein involved in the elongation and maintenance of stereocilia in both inner hair cells (IHCs) and outer hair cells (OHCs)"
    explanation: Ultrastructural demonstration that the lesion is one of stereocilia elongation and maintenance.
  - reference: PMID:12833159
    reference_title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "this novel PDZ domain-containing molecule acts as an organizer of submembranous molecular complexes that control the coordinated actin polymerization and membrane growth of stereocilia"
    explanation: >-
      The authors' mechanistic account of how whirlin controls elongation. Graded INDIRECT
      because it is offered as a suggestion from the phenotype rather than a measurement.
  - reference: PMID:27117407
    reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "Lack of both isoforms causes abnormally short stereocilia and profound deafness and vestibular dysfunction."
    explanation: Links complete whirlin loss to short stereocilia and to profound deafness in the mouse.
  - reference: PMID:27117407
    reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "WHRN-S expression, however, is sufficient to maintain stereocilia bundle morphology and function in a subset of hair cells, resulting in some auditory response and no overt vestibular dysfunction."
    explanation: >-
      Shows the two isoforms are not interchangeable, and that retaining the short isoform
      alone converts profound deafness into a milder loss in the mouse.
- name: Hair Bundle Mechanotransduction Failure
  description: >-
    With short, disordered bundles the hair cell cannot convert sound-induced deflection
    into a receptor potential, and the cochlea does not transmit. The transduction
    machinery itself is not the lesion in DFNB31 - the bundle architecture it depends on
    is - which is why the deficit is sensorineural and cochlear rather than retrocochlear.
  biological_scale: CELLULAR
  cell_types:
  - preferred_term: cochlear hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  biological_processes:
  - preferred_term: detection of mechanical stimulus involved in hearing
    modifier: DECREASED
    term:
      id: GO:0050910
      label: detection of mechanical stimulus involved in sensory perception of sound
  downstream:
  - target: Profound Sensorineural Hearing Impairment
    description: >-
      The clinical endpoint of the chain: a cochlear sensory deficit at the severe end of
      the range.
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:27117407
    reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "While the Whrnwi/wi mutant is profoundly deaf and exhibits circling and headbobbing behavior, we found that the Whrntm1b mutant shows only moderate to severe hearing loss"
    explanation: >-
      Ties bundle state to auditory outcome across two mouse alleles. INDIRECT for the human
      claim because the measured outcome is murine auditory function.
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: "USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
    explanation: The human endpoint, and the contrast with the allelic syndromic disease.
phenotypes:
- category: Auditory
  name: Profound Sensorineural Hearing Impairment
  description: >-
    Profound sensorineural hearing loss is the defining and, so far as the reported families
    go, the only clinical feature of DFNB31. The Tunisian kindred is described as congenital
    and profound; the review summarising the published patients records profound
    sensorineural loss with normal vision as what distinguishes DFNB31 from allelic USH2D.
  phenotype_term:
    preferred_term: Profound sensorineural hearing impairment
    term:
      id: HP:0011476
      label: Profound sensorineural hearing impairment
  notes: >-
    No frequency band is recorded. Profound hearing loss is the ascertainment criterion for
    every reported DFNB31 family, so any band computed from those reports would restate the
    inclusion criterion rather than measure penetrance.
  evidence:
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: "USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
    explanation: States the DFNB31 auditory phenotype and its severity.
  - reference: PMID:15841483
    reference_title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "in a consanguineous Tunisian family segregating congenital profound ARNSHL"
    explanation: Primary report of congenital profound loss in a DFNB31-linked family.
- category: Auditory
  name: Congenital Onset of Hearing Loss
  description: >-
    The loss is present at birth in the family where onset is reported. Only the Tunisian
    kindred is explicitly described as congenital; the other reports do not state onset, so
    this is recorded as a feature of the disease as reported rather than as an established
    universal.
  phenotype_term:
    preferred_term: Congenital sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
  notes: >-
    Denominator is one family. No frequency band, for the same reason as the phenotype
    above.
  evidence:
  - reference: PMID:15841483
    reference_title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "in a consanguineous Tunisian family segregating congenital profound ARNSHL"
    explanation: The one report that states onset describes it as congenital.
genetic:
- name: WHRN variants
  gene_term:
    preferred_term: WHRN
    term:
      id: hgnc:16361
      label: WHRN
  association: Causative
  inheritance:
  - name: Autosomal recessive
    inheritance_term:
      preferred_term: Autosomal recessive inheritance
      term:
        id: HP:0000007
        label: Autosomal recessive inheritance
  features: >-
    WHRN lies at 9q32 and encodes whirlin. The DFNB31 alleles reported so far are truncating
    and lie in the C-terminal half of the protein - R778X in exon 10 and the exon 11
    frameshift G808DfsX11 - while the alleles reported in Usher syndrome type 2D lie in the
    long-isoform-specific N terminus. That positional split is the proposed explanation for
    why one gene produces a syndromic and a non-syndromic disease, and it is a proposal from
    a handful of clinical reports rather than a validated rule. One reported nonsyndromic
    case complicates it: a homozygous missense change at residue 207, inside the
    long-isoform-specific region, in a consanguineous Moroccan patient with severe hearing
    loss. Whether that patient's retina was assessed is not stated in the source read here.
  evidence:
  - reference: PMID:17171570
    reference_title: "A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss."
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "While mutations in the C-terminal half of whirlin have previously been reported in non-syndromic deafness (DFNB31), both alterations identified in our USH2 family affect the long protein isoform."
    explanation: States the positional contrast between the DFNB31 and USH2D allele sets.
  - reference: PMID:17171570
    reference_title: "A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "We propose that mutations causing Usher syndrome are probably restricted to exons 1-6 that are specific for the long isoform and probably crucial for retinal function."
    explanation: >-
      The genotype-phenotype proposal itself. Graded INDIRECT because the authors offer it
      as a hypothesis from two alleles in one family plus the prior DFNB31 reports.
  - reference: PMID:37924449
    reference_title: Novel pathogenic WHRN variant causing hearing loss in a moroccan family.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Exome sequencing in a consanguineous Moroccan patient with severe hearing loss identified a single homozygous mutation"
    explanation: >-
      A homozygous WHRN variant at residue 207 - inside the region the positional rule
      assigns to Usher syndrome - reported in hearing loss. Recorded as a complication of
      that rule, and graded INDIRECT because the source does not report an ophthalmological
      assessment that would settle whether the case is syndromic.
prevalence:
- population: Tunisian families with autosomal recessive nonsyndromic hearing loss
  measure_type: CASES_IN_LITERATURE
  prevalence_class: NOT_YET_DOCUMENTED
  notes: >-
    No prevalence estimate exists. What is on record is a negative screen: after identifying
    the second DFNB31 family, the authors typed 62 further unrelated informative Tunisian
    ARNSHL families and found no linkage to the locus in any of them.
  evidence:
  - reference: PMID:15841483
    reference_title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "we performed linkage analysis in 62 unrelated informative families affected with ARNSHL. No linkage was found to this locus."
    explanation: The negative linkage screen behind the rarity statement.
  - reference: PMID:15841483
    reference_title: Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "we concluded that DFNB31/WHRN is most likely to be a rare cause of ARNSHL in the Tunisian population"
    explanation: The authors' own rarity conclusion.
treatments:
- name: Cochlear Implantation
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: cochlear device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  description: >-
    The standard intervention for congenital profound sensorineural hearing loss. The
    mechanism supports it in principle: the lesion is in the hair bundle, upstream of the
    spiral ganglion an implant stimulates, and no cochlear malformation is described in
    this disease. No outcome data exist for DFNB31 patients specifically.
  target_mechanisms:
  - target: Hair Bundle Mechanotransduction Failure
    treatment_effect: BYPASSES
    description: Bypasses the failed transduction step by stimulating the auditory nerve directly.
  notes: >-
    Carries no evidence item deliberately. The published WHRN literature reports no implant
    outcomes, and the rationale above is this entry's inference from the mechanism, labelled
    as such. The treatment term is the generic surgical action; NCIT:C157820 names the
    device rather than a clinical action and is not reachable from NCIT:C25218, so it is
    attached as a qualifier instead.
- name: Early Identification and Habilitation
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: auditory habilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  description: >-
    Where the loss is congenital and profound, the modifiable outcome is spoken-language
    development and the modifier is how early it is identified and habilitated. Newborn
    hearing screening detects it.
  notes: >-
    No evidence item. This is general practice for congenital profound deafness, not a
    DFNB31 finding.
animal_models:
- name: Whirler mouse (Whrn wi/wi)
  species: Mouse
  genotype: Whrn wi/wi - spontaneous deletion removing most of exons 6-10, ablating both major whirlin isoforms
  publication: PMID:12833159
  description: >-
    The spontaneous mutant through which the gene was found. Whirler mice do not respond to
    sound and their inner and outer hair cells carry abnormally short stereocilia. Because
    the deletion removes both major isoforms, the model is the null end of the WHRN allelic
    series rather than a copy of any particular human allele.
  modeled_mechanisms:
  - target: Failure of Stereocilia Elongation and Bundle Organization
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: >-
      Ultrastructural analysis of the organ of Corti in this mutant is the primary evidence
      that whirlin is required for stereocilia elongation and maintenance.
    limitations: >-
      The whirler deletion sits in the 3' region shared by both isoforms, which is where the
      human DFNB31 alleles fall, so it matches them in position; but it removes both
      isoforms outright rather than truncating them, so it may be more severe than the
      human lesion. The mutant also
      circles and head-bobs, a vestibular phenotype not reported in DFNB31 patients.
    readouts:
    - name: Stereocilia length in inner and outer hair cells
      target: Failure of Stereocilia Elongation and Bundle Organization
      direction: DECREASED
      interpretation: Short stereocilia in both hair cell types is the structural correlate of this node.
      evidence:
      - reference: PMID:12833159
        reference_title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "detailed ultrastructural analysis of sensory hair cells in the organ of Corti of the inner ear indicates that the whirler gene encodes a protein involved in the elongation and maintenance of stereocilia in both inner hair cells (IHCs) and outer hair cells (OHCs)"
        explanation: The ultrastructural measurement behind this readout.
  evidence:
  - reference: PMID:12833159
    reference_title: "Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The whirler mouse mutant (wi) does not respond to sound stimuli"
    explanation: Establishes the model's auditory phenotype.
- name: Whrn tm1b long-isoform-null mouse
  species: Mouse
  genotype: Whrn tm1b(KOMP)Wtsi homozygote - exon 4 deleted, expresses WHRN-S but not WHRN-L
  publication: PMID:27117407
  description: >-
    The isoform-dissecting model. Retaining the short isoform alone leaves inner hair cell
    bundles close to normal, damages outer hair cell bundles, and produces moderate to
    severe rather than profound hearing loss with no overt vestibular dysfunction. It is
    the experimental basis for the proposal that isoform-specific loss explains the
    difference between DFNB31 and USH2D.
  modeled_mechanisms:
  - target: Failure of Stereocilia Elongation and Bundle Organization
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      Reproduces bundle disorganization, but only in outer hair cells, and with a milder
      auditory outcome than DFNB31.
    limitations: >-
      This allele is the inverse of the human DFNB31 genotype: it removes the long isoform
      and spares the short one, whereas the reported DFNB31 alleles truncate the C terminus
      shared by both. It models the allelic contrast rather than the human disease.
    readouts:
    - name: Outer hair cell bundle morphology and function
      target: Failure of Stereocilia Elongation and Bundle Organization
      direction: ALTERED
      interpretation: Isoform-restricted bundle damage, sparing inner hair cells.
      evidence:
      - reference: PMID:27117407
        reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "WHRN-S expression, however, is sufficient to maintain stereocilia bundle morphology and function in a subset of hair cells, resulting in some auditory response and no overt vestibular dysfunction."
        explanation: The bundle and auditory readout in this allele.
- name: AAV8-whirlin gene transfer in whirler mice
  species: Mouse
  genotype: Whrn wi/wi treated with AAV8 carrying wild-type whirlin cDNA by neonatal round-window injection
  publication: PMID:26307667
  description: >-
    A rescue experiment rather than a disease model: delivering wild-type whirlin cDNA to
    neonatal whirler cochleas restored normal stereocilia length and bundle architecture in
    infected hair cells and increased inner hair cell survival relative to the untreated
    contralateral ear.
  modeled_mechanisms:
  - target: Failure of Stereocilia Elongation and Bundle Organization
    relationship: RESCUES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      Restoring whirlin restores the bundle, which is the strongest available evidence that
      the bundle phenotype is a direct consequence of whirlin loss rather than a downstream
      or developmental side effect.
    limitations: >-
      Neonatal delivery in a mouse with a double-isoform-null allele. Round-window delivery
      partially lengthened inner but not outer hair cell stereocilia and did not restore
      hearing, so this experiment is a structural rescue without a functional one. That
      negative result is specific to the route: a later study delivering the same construct
      through the posterior semicircular canal reached more cochlear hair cells and partially
      improved both auditory and vestibular function. The claim that treating adult mice did
      not restore stereocilia comes from the deep-research report's reading of full text
      that could not be fetched and is not asserted here.
    readouts:
    - name: Stereocilia length and bundle architecture after transduction
      target: Failure of Stereocilia Elongation and Bundle Organization
      direction: RESTORED
      interpretation: Structural rescue in transduced hair cells.
      evidence:
      - reference: PMID:26307667
        reference_title: Gene Therapy Restores Hair Cell Stereocilia Morphology in Inner Ears of Deaf Whirler Mice.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "whirlin expression was detected in infected hair cells (IHCs), and normal stereocilia length and bundle architecture were restored"
        explanation: The structural rescue readout.
    - name: Hearing after round-window delivery
      target: Failure of Stereocilia Elongation and Bundle Organization
      direction: UNCHANGED
      interpretation: >-
        Hearing loss was not restored despite partial stereocilia lengthening in inner hair
        cells, so the structural rescue did not carry through to function by this route.
      evidence:
      - reference: PMID:30831381
        reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
        supports: SUPPORT
        quote_role: REVIEW_SYNTHESIS
        evidence_source: MODEL_ORGANISM
        snippet: "The cochlear round window delivery partially increases the stereocilia length in IHCs but not OHCs, and hearing loss in Whrnwi mice is not restored (Chien et al., 2015)."
        explanation: >-
          The review's summary of the functional outcome of this experiment, which the
          primary paper's abstract does not report.
    evidence:
    - reference: PMID:30831381
      reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
      supports: SUPPORT
      quote_role: REVIEW_SYNTHESIS
      evidence_source: MODEL_ORGANISM
      snippet: "Posterior semicircular canal delivery of AAV-FL-whirlin was found to increase the stereociliary length in utricular hair cells as well as cochlear inner hair cells, and partially improve both the vestibular and auditory function of Whrnwi mice (Isgrig et al., 2017)."
      explanation: >-
        A different delivery route partially restored function, so the round-window
        negative result reflects the route rather than a limit of whirlin replacement.
  evidence:
  - reference: PMID:26307667
    reference_title: Gene Therapy Restores Hair Cell Stereocilia Morphology in Inner Ears of Deaf Whirler Mice.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Wild-type whirlin cDNA was delivered via adeno-associated virus (AAV8) by injection through the round window of the cochleas in neonatal whirler mice."
    explanation: Describes the delivery route and construct.
differential_diagnoses:
- name: Usher syndrome type 2D
  description: >-
    The allelic syndromic disease, caused by variants in the same gene. It is the
    differential that matters here, because the distinction is not made on the audiogram
    alone: USH2D hearing loss is moderate rather than profound, and the discriminating
    feature is retinitis pigmentosa, which begins around the second decade. A child with
    WHRN-related hearing loss and a variant in the long-isoform-specific N terminus is
    therefore a candidate for retinal surveillance rather than a settled DFNB31 diagnosis.
  evidence:
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: "USH2D patients have moderate sensorineural hearing loss and RP, while DFNB31 patients have profound sensorineural hearing loss and normal vision."
    explanation: The clinical discriminator between the two WHRN diseases.
  - reference: PMID:17171570
    reference_title: "A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss."
    supports: SUPPORT
    directness: DIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "this is the first case of USH2 that is allelic to non-syndromic deafness"
    explanation: Establishes that the two WHRN diseases are allelic, which is why this differential exists at all.
discussions:
- discussion_id: dfnb31_vestibular_mouse_human_mismatch
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Whirlin-null mice have overt vestibular dysfunction and no published WHRN patient
    reports a vestibular deficit. Is human DFNB31 genuinely vestibular-sparing, or has
    vestibular function never been tested?
  attaches_to:
  - pathophysiology#Failure of Stereocilia Elongation and Bundle Organization
  rationale: >-
    Whirlin is expressed in vestibular hair cells as well as cochlear ones, and the same
    stereocilia machinery builds both bundles, so a vestibular phenotype is what the
    mechanism predicts. The whirler mouse circles and head-bobs, and the mouse lacking both
    isoforms has profound deafness with vestibular dysfunction. Against that, the review
    summarising the published WHRN patients records that none of them self-reported a
    vestibular deficit - which is a statement about what patients volunteered, not about
    what testing showed. Whether DFNB31 spares the human vestibular system, or whether the
    deficit is present and compensated or simply unmeasured, changes what should be offered
    clinically: vestibular assessment and balance habilitation in a deaf child are not
    routine unless a deficit is suspected.
  proposed_experiments:
  - experiment_id: exp_dfnb31_formal_vestibular_testing
    name: Formal vestibular testing of a DFNB31 cohort
    description: >-
      Vestibular-evoked myogenic potentials, caloric testing and video head impulse testing
      in genotyped DFNB31 patients, with age-matched controls, rather than symptom
      questionnaires.
    would_support:
    - pathophysiology#Failure of Stereocilia Elongation and Bundle Organization
    supporting_outcome:
    - Measurable vestibular hypofunction in DFNB31 patients would show that the murine
      phenotype translates and that the absence of self-reported symptoms reflects
      compensation rather than sparing.
    would_refute:
    - pathophysiology#Failure of Stereocilia Elongation and Bundle Organization
    refuting_outcome:
    - Normal vestibular function on formal testing would establish a real
      cochlear-restricted phenotype in humans and make the mouse a poor model for this
      aspect of the disease.
  evidence:
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    directness: DIRECT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: HUMAN_CLINICAL
    snippet: "None of these aforementioned patients self-reported any vestibular deficits."
    explanation: The human side of the mismatch, and the reason it is weak - self-report, not testing.
  - reference: PMID:30831381
    reference_title: "Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina."
    supports: SUPPORT
    quote_role: REVIEW_SYNTHESIS
    evidence_source: MODEL_ORGANISM
    snippet: "However, both Whrnneo and Whrnwi mice show similar severe to profound loss of linear vestibular evoked potential (VsEP) responses."
    explanation: >-
      On objective testing both mouse alleles lose otolith responses, including the one
      without overt balance behaviour, so a deficit can be present where behaviour misses it.
      That is the case for formal testing rather than self-report in patients.
  - reference: PMID:27117407
    reference_title: Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
    supports: SUPPORT
    directness: DIRECT
    evidence_source: MODEL_ORGANISM
    snippet: "Lack of both isoforms causes abnormally short stereocilia and profound deafness and vestibular dysfunction."
    explanation: The murine side of the mismatch.
- discussion_id: dfnb31_isoform_position_genotype_phenotype_rule
  kind: KNOWLEDGE_GAP
  prompt: >-
    Is the 5' / 3' positional rule - long-isoform-specific N-terminal alleles give Usher
    syndrome type 2D, C-terminal alleles give non-syndromic DFNB31 - actually a rule, or a
    pattern in a handful of families?
  attaches_to:
  - genetic#WHRN variants
  rationale: >-
    The rule is the entry's mechanistic account of why one gene gives two diseases, and it
    is doing real clinical work: it is what would decide whether a WHRN-positive deaf child
    is put under retinal surveillance. But it rests on two alleles in one German USH2 family
    set against the DFNB31 alleles known in 2007, and its authors stated it as a proposal.
    One later nonsyndromic report carries a homozygous missense change at residue 207, inside
    the long-isoform-specific region, without a reported retinal assessment. Until a
    genotype-stratified cohort with ophthalmological follow-up exists, the rule should not be
    used to withhold retinal surveillance.
  proposed_experiments:
  - experiment_id: exp_dfnb31_genotype_stratified_retinal_followup
    name: Genotype-stratified retinal follow-up of WHRN-positive hearing loss
    description: >-
      Assemble WHRN biallelic cases from hearing loss cohorts, classify alleles by whether
      they affect the long-isoform-specific exons, and follow retinal function
      longitudinally into the third decade.
    would_support:
    - genetic#WHRN variants
    supporting_outcome:
    - Retinitis pigmentosa confined to carriers of long-isoform-specific alleles would turn
      the proposal into a usable clinical rule.
    would_refute:
    - genetic#WHRN variants
    refuting_outcome:
    - Retinal degeneration in carriers of C-terminal alleles, or its absence in carriers of
      N-terminal ones, would show that isoform position does not determine the syndromic
      boundary.
  evidence:
  - reference: PMID:17171570
    reference_title: "A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "We propose that mutations causing Usher syndrome are probably restricted to exons 1-6 that are specific for the long isoform and probably crucial for retinal function."
    explanation: The proposal, in the authors' own hedged wording.
📚

References & Deep Research

References

8
Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.
No top-level findings curated for this source.
Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.
No top-level findings curated for this source.
A novel gene for Usher syndrome type 2: mutations in the long isoform of whirlin are associated with retinitis pigmentosa and sensorineural hearing loss.
No top-level findings curated for this source.
Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms in the cochlea, vestibular organs, and retina.
No top-level findings curated for this source.
Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium.
No top-level findings curated for this source.
Alternative Splice Forms Influence Functions of Whirlin in Mechanosensory Hair Cell Stereocilia.
No top-level findings curated for this source.
Gene Therapy Restores Hair Cell Stereocilia Morphology in Inner Ears of Deaf Whirler Mice.
No top-level findings curated for this source.
Novel pathogenic WHRN variant causing hearing loss in a moroccan family.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Identifiers. OMIM #607084 (DFNB31) is the OMIM key for this concept, and WHRN is hgnc:16361 at 9q32. They are recorded in prose because the schema's `mappings` block carries `mondo_mappings` only and has no slot for an OMIM identifier. Scope, and the entity next door. This entry is the non-syndromic disease only. WHRN also causes Usher syndrome type 2D, which is curated in `Usher_Syndrome.yaml` as a WHRN subtype; the allelic relationship between the two is curated here because it is what explains the DFNB31 phenotype, but USH2D itself is not re-curated. The other WHRN neighbour in the KB, `Autosomal_Recessive_Nonsyndromic_Hearing_Loss_48`, is a CIB2 entry that mentions whirlin only in mechanism prose and argues that CIB2's stereocilia role is not exercised through whirlin; it is not coverage of this disease. Evidence base and its shape. The human evidence for DFNB31 is thin, and worth stating plainly: the founding report (PMID:12833159) names the human locus but is largely a mouse paper, the second family (PMID:15841483) is one consanguineous Tunisian kindred, and a third (PMID:37924449) is one consanguineous Moroccan patient. The allele list this entry quotes - R778X in exon 10, G808DfsX11 in exon 11 - comes from a review (PMID:30831381) summarising those primary reports, and is graded `REVIEW_SYNTHESIS` accordingly. No frequency bands are recorded on the phenotypes, because with three reported families every band would be computed from an ascertainment criterion rather than from a cohort. Mechanism evidence is mouse and cell biology throughout, and is graded that way. Whirlin's tip localization and its dynamic gradation across stereocilia rows (PMID:15590699), the isoform-specific localization and the WHRN-S/EPS8 length-regulation complex (PMID:27117407), and the AAV8 rescue (PMID:26307667) are all mouse work. None of it is used as the sole support for a human phenotype. Two things this entry deliberately does not assert. First, it does not claim that DFNB31 patients have been shown to have normal retinas by examination. The review states that DFNB31 patients have normal vision, and that is recorded as written, but no source read here reports a systematic ophthalmological assessment of a DFNB31 cohort. Second, it does not resolve vestibular involvement. The whirler mouse circles and head-bobs, and the double-isoform-null mouse has overt vestibular dysfunction, while the review records that none of the published WHRN patients self-reported a vestibular deficit - self-report, not testing. That disagreement is recorded as a HUMAN_MODEL_MISMATCH discussion rather than resolved. Bilaterality and progression are not curated. Neither "bilateral" nor a progression course is described for DFNB31 in the references read here. Recessive cochlear disease is bilateral in expectation, but expectation is not a source, so `HP:0008619` is not bound. Deep research. A Falcon deep-research report is committed alongside this entry. The query was seeded with a disambiguated disease name ("DFNB31 WHRN whirlin-related autosomal recessive nonsyndromic hearing loss") rather than the bare numbered locus name, because numbered loci are where providers substitute a different disease. It came back on topic: `just preflight-dr` passed against MONDO:0011767 with WHRN mentioned 66 times and the correct OMIM number (607084) present, and its own reference validation resolved 9 of 9 citations with a confabulation rate of 0. It was used as a lead source only - every snippet in this entry is anchored to a PMID fetched into `references_cache/` and read directly - and it did not change any conclusion drawn from the primary literature. The report states that the AAV8 rescue restored stereocilia morphology but did **not** improve hearing, and that treating adult mice did not restore stereocilia at all. The first half is confirmed by the whirlin isoform review (PMID:30831381), which is cached in full and is cited on the AAV8 model's readout; the same review reports that posterior semicircular canal delivery partially improved hearing and balance, so the negative result is route-specific. The adult-treatment claim is attributed to the gene-therapy paper's full text, which is not cached (its abstract and DOI record do not contain it), so it is not asserted here.

Create: Autosomal Recessive Nonsyndromic Hearing Loss 31 (DFNB31, WHRN) · 2026-09-16T22:07:26Z · View source

Curation outcome for MONDO:0011767 (autosomal recessive nonsyndromic hearing loss 31; DFNB31, WHRN, OMIM 607084) is a standalone kb/disorders/ entry, consistent with the dozen-plus DFNA/DFNB per-locus entries already in the KB. The two WHRN neighbours were checked and neither is coverage: Usher_Syndrome.yaml curates USH2D as a WHRN subtype, which is the allelic syndromic disease and not this one, and Autosomal_Recessive_Nonsyndromic_Hearing_Loss_48 is a CIB2 entry that mentions whirlin only in prose while arguing CIB2's stereocilia role is not exercised through whirlin. Content: a four-node pathograph from biallelic WHRN loss of function through loss of whirlin from the stereocilia tip complex, failure of stereocilia elongation and bundle organization, to hair bundle mechanotransduction failure; two wired phenotypes; a genetic section built around the isoform-position genotype-phenotype question; a negative-linkage prevalence record; cochlear implantation and early habilitation as treatments, both deliberately evidence-free with the reason stated; three mouse models (the whirler Whrn wi/wi null, the Whrn tm1b long-isoform null, and the AAV8 rescue) each with modeled_mechanisms, model_scale, limitations and readouts; Usher syndrome type 2D as the differential; and two discussions. Thirty evidence snippets across eight PMIDs, all verified. The mechanistically interesting content is the allelic relationship with USH2D. DFNB31 patients have profound hearing loss and normal vision while USH2D patients have moderate loss with retinitis pigmentosa, and the proposed explanation is that WHRN's long and short isoforms are hit differently: the DFNB31 alleles reported so far are C-terminal truncations and the USH2D alleles lie in the long-isoform-specific N terminus. That is recorded as the authors' proposal rather than a rule, with a KNOWLEDGE_GAP discussion, because it rests on two alleles in one family and because one later nonsyndromic report carries a homozygous missense change at residue 207 inside the region the rule would assign to Usher syndrome, with no reported retinal assessment. A second discussion records a HUMAN_MODEL_MISMATCH: whirlin-null mice circle and head-bob and the double-isoform-null mouse has overt vestibular dysfunction, while the review states that no published WHRN patient self-reported a vestibular deficit - self-report, not testing. Deep research: a Falcon report is committed. The query was seeded with a disambiguated disease name rather than the numbered locus, because numbered loci are where providers substitute a different disease; the entry's name: field was temporarily set to that string and restored before commit. preflight-dr PASSed against MONDO:0011767 with WHRN mentioned 66 times and the correct OMIM 607084 present, and the report's own reference validation resolved 9 of 9 citations at confabulation rate 0. The report was used as a lead only and changed no conclusion. One of its claims - that the AAV8 rescue did not improve ABR sensitivity and that adult treatment did not restore stereocilia - is attributed to full text this entry could not fetch, so it is recorded in notes and in the model's limitations as the report's unverified claim rather than asserted as evidence. Deleted stubs/Autosomal_Recessive_Nonsyndromic_Hearing_Loss_31.yaml. Validation: just validate (30/30 snippets, all PMID, no prefix skips), validate-terms, check-entity-refs, check-duplicate-keys, check-causal-targets, check-qualifier-terms, check-folded-hyphens, check-enum-values, check-stubs, validate-disorders, whole-KB check-title-snippets, check-snippet-length, check-snippet-grading, plus a manual orphan audit: every phenotype and non-root node is targeted, and the only untargeted node is the root trigger.

Falcon ▸
Disease Characteristics Research Template
Edison Scientific Literature 27 citations 2026-09-16T15:00:10.263108

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

  • Disease Name: DFNB31 WHRN whirlin-related autosomal recessive nonsyndromic hearing loss
  • MONDO ID: MONDO:0011767 (if available)
  • Category: Mendelian

Research Objectives

Please provide a comprehensive research report on DFNB31 WHRN whirlin-related autosomal recessive nonsyndromic hearing loss covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.


1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

  • What is the disease? Provide a concise overview.
  • What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
  • What are the common synonyms and alternative names?
  • Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

  • Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
  • Risk Factors:

    Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases

  • Genetic risk factors (causal variants, susceptibility loci, modifier genes)
  • Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
  • Protective Factors:

    Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases

  • Genetic protective factors (protective variants, modifier alleles)
  • Environmental protective factors (diet, lifestyle, exposures that reduce risk)
  • Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

    Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

  • Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

    Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene

  • Pathogenic Variants:
  • Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
  • Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
  • Variant type/class (missense, frameshift, nonsense, splice-site, structural)
  • Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
  • Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
  • Functional consequences (loss of function, gain of function, dominant negative)
  • Modifier Genes: Genes that modify disease severity or expression
  • Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

    Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

  • Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

    Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases

  • Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

    Search first: CDC databases, WHO, PubMed, NHANES

  • Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

    Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Present this section as an ordered causal chain first, then the detail below. Open with a numbered sequence of mechanistic steps running from the initiating lesion (mutation, exposure, infection) to the clinical manifestation, one step per line, each naming what it causes next. State the causal verb explicitly ("leads to", "results in") and say where a step is inferred rather than demonstrated. Where the mechanism branches, show the branch. The categories below are a checklist of what to cover within those steps, not the organizing structure — a step may draw on several of them, and a category may contribute to several steps.

  • Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

    Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc

  • Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

    Search first: Gene Ontology (GO), Reactome, KEGG, PubMed

  • Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

    Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold

  • Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

    Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA

  • Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

    Search first: ImmPort, Immunome Database, IEDB, Gene Ontology

  • Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

    Search first: PubMed, Gene Ontology, Reactome

  • Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

    Search first: BRENDA, UniProt, KEGG, OMIM, PubMed

  • Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

    Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth

  • Molecular Profiling (if available):
  • Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
  • Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
  • Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
  • Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
  • Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
  • Advanced Technologies (if applicable):
  • Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
  • Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
  • Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
  • Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

  • Organ Level:
  • Primary organs directly affected
  • Secondary organ involvement (complications, secondary effects)
  • Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

    Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT

  • Tissue and Cell Level:
  • Specific tissue types affected (epithelial, connective, muscle, nervous)
  • Specific cell populations targeted (with Cell Ontology terms)

    Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB

  • Subcellular Level:
  • Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

    Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas

  • Localization:
  • Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
  • Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

  • Onset:
  • Typical age of onset (congenital, pediatric, adult, geriatric)
  • Onset pattern (acute, subacute, chronic, insidious)

    Search first: OMIM, Orphanet, HPO, PubMed

  • Progression:
  • Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
  • Progression rate (rapid, slow, variable)
  • Disease course pattern (episodic, relapsing-remitting, progressive, stable)
  • Disease duration (self-limited, chronic lifelong)

    Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM

  • Patterns:
  • Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
  • Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

  • Epidemiology:
  • Prevalence (cases per 100,000 at given time)
  • Incidence (new cases per 100,000 per year)

    Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries

  • For Genetic Etiology:
  • Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
  • Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
  • Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
  • Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
  • Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
  • Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
  • Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
  • Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
  • Population Demographics:
  • Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
  • Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
  • Geographic distribution of specific variants
  • Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
  • Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

  • Clinical Tests:
  • Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
  • Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
  • Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
  • Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
  • Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
  • Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
  • Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
  • Genetic Testing:

    Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen

  • Overview of recommended genetic testing approach
  • Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
  • Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
  • Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
  • Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
  • Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
  • Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
  • FISH > Search first: ClinVar, cytogenetics databases, PubMed
  • Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
  • Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
  • Omics-Based Diagnostics (if applicable):
  • RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
  • Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
  • Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
  • Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
  • Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
  • Clinical Criteria:
  • Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
  • Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
  • Screening:
  • Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

  • Survival and Mortality:
  • Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
  • Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
  • Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
  • Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
  • Morbidity and Function:
  • Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
  • Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
  • Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
  • Disease Course:
  • Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
  • Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
  • Prediction:
  • Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
  • Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

  • Pharmacotherapy:
  • Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
  • Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
  • Advanced Therapeutics:
  • Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
  • Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
  • RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
  • Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
  • Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
  • Surgical and Interventional:
  • Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
  • Supportive and Rehabilitative:
  • Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
  • Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
  • Experimental:
  • Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
  • Treatment Outcomes:
  • Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
  • Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
  • Treatment Strategy:
  • Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
  • Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
  • Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

  • Prevention Levels:
  • Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
  • Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
  • Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
  • Immunization: Vaccine strategies (if applicable)

    Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database

  • Screening and Early Detection:
  • Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
  • Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
  • Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
  • Behavioral Interventions: Lifestyle modifications to reduce risk

    Search first: CDC, WHO, behavioral intervention databases, Cochrane Library

  • Counseling: Genetic counseling (risk assessment, family planning guidance)

    Search first: NSGC resources, ACMG guidelines, GeneReviews

  • Public Health:
  • Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
  • Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
  • Prophylaxis: Preventive medications or procedures

    Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

  • Taxonomy: Species affected (with NCBI Taxon identifiers)

    Search first: NCBI Taxonomy

  • Breed: Specific breeds affected (with VBO identifiers if applicable)

    Search first: VBO (Vertebrate Breed Ontology)

  • Gene: Orthologous genes in other species (with NCBI Gene IDs)

    Search first: NCBI Gene

  • Natural Disease:
  • Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
  • Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
  • Comparative Biology:
  • Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
  • Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
  • Transmission (if applicable):
  • Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
  • Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

  • Model Types:
  • Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
  • Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
  • Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
  • Genetic Models:
  • Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
  • Model Characteristics:
  • Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
  • Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
  • Applications:
  • Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
  • Resources:
  • Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic and clinical claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes from abstracts where possible to support key statements
  • Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

DFNB31 / WHRN-related autosomal-recessive nonsyndromic hearing loss

Executive summary

DFNB31 is a rare Mendelian sensorineural hearing-loss disorder caused by biallelic germline pathogenic variants in WHRN, which encodes the PDZ-domain scaffold protein whirlin. The disease is usually described as congenital or prelingual, bilateral, severe-to-profound hearing loss without retinal disease. It must be distinguished from WHRN-related Usher syndrome type 2D (USH2D), in which hearing impairment accompanies progressive rod–cone retinal degeneration. Open Targets specifically maps WHRN (ENSG00000095397) to autosomal-recessive nonsyndromic hearing loss 31, MONDO:0011767. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN, mathur2019ushersyndromeand pages 2-3)

The strongest mechanistic model is that loss of stereociliary tip-localized whirlin disrupts the MYO15A–WHRN–EPS8 protein complex, causing deficient elongation and organization of actin-rich cochlear hair-cell stereocilia and consequently defective mechanotransduction. Mutation location and transcript/isoform disruption influence whether disease remains cochlear or also affects the retina, although this genotype–phenotype rule is not absolute. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 12-13)

No approved molecular therapy or WHRN-targeted human clinical trial was identified. Hearing aids, cochlear implantation when indicated, communication access, and early habilitation remain standard care. Neonatal AAV8-mediated whirlin supplementation restored stereociliary morphology and improved inner-hair-cell survival in whirler mice but did not restore ABR hearing sensitivity; treatment of adults did not restore stereociliary architecture. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9, brotto2024autosomalrecessivenonsyndromic pages 2-3)

The following structured summary is suitable for knowledge-base ingestion.

Domain Established finding Evidence type Suggested ontology identifiers Confidence / gap
Identity Autosomal recessive nonsyndromic hearing loss 31 (DFNB31) is a Mendelian sensorineural hearing-loss disorder caused by biallelic WHRN variants. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN, mathur2015distinctexpressionand pages 2-2) Aggregated disease–target resources; human genetic studies MONDO:0011767; OMIM phenotype label: DFNB31; MeSH label: Hearing Loss, Sensorineural High confidence for gene–disease relationship; dedicated ICD-10/ICD-11 codes are unavailable.
Core phenotype Usually bilateral, congenital or prelingual, severe-to-profound sensorineural hearing loss; the canonical DFNB31 description emphasizes profound hearing loss with normal vision. (mathur2019ushersyndromeand pages 2-3) Human pedigrees and literature synthesis HPO: Sensorineural hearing impairment; Bilateral sensorineural hearing impairment; Congenital onset; Profound hearing impairment; Absent speech or delayed speech-and-language development High confidence for hearing loss; exact frequencies and longitudinal progression rates are poorly quantified because reported cohorts are small.
Gene and protein WHRN encodes whirlin, a cytoskeletal scaffolding protein with PDZ domains and a proline-rich region; the gene is located on chromosome 9q32–q34. (mathur2015distinctexpressionand pages 2-2, souissi2021novelpathogenicmutations pages 11-12) Human genetics; molecular studies HGNC label: WHRN; UniProt label: Whirlin; GO label: protein-containing complex scaffold activity High confidence; transcript numbering and historical use of DFNB31 as a gene symbol can complicate variant normalization.
Isoforms Principal products include full-length whirlin with three PDZ domains, C-terminal whirlin containing the proline-rich region and PDZ3, and N-terminal forms containing PDZ1 and/or PDZ2. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 2-2, mathur2019ushersyndromeand pages 2-3) Mouse tissue expression, proteomics and molecular localization Protein isoform labels: full-length whirlin, N-terminal whirlin, C-terminal whirlin; GO label: alternative mRNA splicing High confidence in mice; exact expression and functional equivalence of every human transcript remain incompletely resolved.
Molecular mechanism Loss of tip-localized whirlin disrupts the MYO15A–WHRN–EPS8 elongation complex, leading to abnormally short and disorganized actin-rich stereocilia and impaired hair-cell mechanosensation. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 12-13) Biochemical interaction, localization and mouse-mutant evidence GO: stereocilium organization; actin filament organization; sensory perception of sound; mechanosensory behavior; auditory receptor-cell stereocilium High mechanistic confidence in model organisms; the complete causal sequence has not been directly observed in living human cochleae.
Anatomy and cell types Primary disease sites are the cochlea and organ of Corti, particularly inner and outer hair-cell stereociliary bundles; whirlin also occurs in vestibular hair cells and, in long-isoform disease, photoreceptor periciliary regions. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 12-13, mathur2015astudyof pages 1-2) Mouse immunolocalization and functional studies UBERON labels: cochlea, organ of Corti, inner ear, vestibular organ, retina; CL labels: inner hair cell, outer hair cell, vestibular hair cell, retinal photoreceptor cell; GO label: stereocilium High confidence for cochlear localization; human vestibular involvement in isolated DFNB31 is insufficiently characterized.
Inheritance Biallelic germline pathogenic variants produce autosomal recessive disease; heterozygous parents are generally clinically unaffected under the established human model. Human segregation studies and Mendelian disease curation HPO: Autosomal recessive inheritance; GENO label: germline allele High confidence; penetrance is presumed high for severe biallelic loss-of-function genotypes, but formal penetrance estimates and verified human modifier genes are unavailable.
Pathogenic variants Reported DFNB31-associated C-terminal truncating alleles include p.Arg778Ter (R778X) and p.Gly808AspfsTer11 (G808DfsX11); pathogenic WHRN alleles also include other nonsense, frameshift and splice-disrupting variants. (mathur2015distinctexpressionand pages 10-11, mathur2019ushersyndromeand pages 2-3) Human pedigrees, segregation and model comparison Sequence Ontology labels: stop gained, frameshift variant, splice-region/splice-donor/splice-acceptor variant; ClinVar classification labels: pathogenic or likely pathogenic when criteria are met Variant-level confidence must be assessed individually using current ClinVar/ACMG evidence, segregation and population frequency; no single founder allele explains most cases globally.
Distinction from USH2D C-terminal variants that preserve a functional retinal N-terminal product tend to cause isolated DFNB31, whereas N-terminal variants disrupting full-length whirlin in ear and retina tend to cause moderate-to-severe hearing loss plus retinitis pigmentosa (USH2D). This is a useful but nonabsolute isoform-based correlation. (mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 2-2, mathur2015distinctexpressionand pages 10-11, mathur2019ushersyndromeand pages 2-3) Human genotype–phenotype observations plus allele-specific mouse models MONDO label: Usher syndrome type 2D; HPO: Retinitis pigmentosa, Rod-cone dystrophy, Visual-field defect Moderate confidence rather than a deterministic rule; retinal surveillance remains prudent after a WHRN diagnosis, especially for N-terminal or uncertain alleles.
Diagnosis Confirm sensorineural hearing loss with newborn screening followed by diagnostic ABR, otoacoustic emissions and age-appropriate behavioral/pure-tone audiometry; establish etiology using a comprehensive hearing-loss panel including WHRN, with CNV analysis and segregation. Exome or genome sequencing is appropriate when panel testing is negative. Standard genetic-hearing-loss practice; targeted sequencing studies; expert curation LOINC labels: auditory brainstem response, otoacoustic emissions, pure-tone audiometry; NCIT labels: Genetic Testing, Whole Exome Sequencing, Whole Genome Sequencing High confidence for the general workflow; no WHRN-specific biochemical biomarker, biopsy, metabolomic or epigenomic diagnostic is validated.
Additional evaluation Ophthalmic history and baseline examination, with fundus imaging/OCT and electroretinography when indicated, help exclude evolving USH2D; vestibular testing is reasonable for imbalance or delayed motor milestones because mouse mutants show vestibular dysfunction. (mathur2015astudyof pages 1-2, terrasa2026ushersyndrometype pages 2-4) Human syndromic differential diagnosis; mouse vestibular evidence HPO: Vestibular dysfunction, Abnormal electroretinogram; NCIT labels: Electroretinography, Optical Coherence Tomography, Vestibular Function Test Retinal evaluation is clinically important; routine vestibular screening specifically for DFNB31 lacks disease-specific outcome data.
Current treatment No approved WHRN-directed pharmacotherapy exists. Management uses hearing aids when residual hearing is aidable, cochlear implantation for severe-to-profound loss with inadequate aided benefit, and early speech-language, auditory-verbal or sign-language intervention. Standard-of-care extrapolation from congenital genetic sensorineural hearing loss NCIT labels: Hearing Aid, Cochlear Implantation, Speech Therapy, Auditory Rehabilitation Strong general clinical support, but no DFNB31-specific controlled response rates or genotype-based implantation thresholds are available.
Experimental AAV8 therapy Neonatal round-window delivery of AAV8 carrying 2,724-bp long Whrn cDNA restored whirlin expression, stereociliary length/bundle architecture and inner-hair-cell survival in whirler mice; however, it did not improve ABR hearing sensitivity at tested frequencies. Adult treatment did not restore stereociliary length or row number. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9, brotto2024autosomalrecessivenonsyndromic pages 2-3) Preclinical mouse gene-supplementation experiment NCIT labels: Gene Therapy, Recombinant Adeno-Associated Viral Vector; NCBI Taxon: Mus musculus; GO label: stereocilium organization Morphological rescue is reproducible evidence of target engagement, but functional efficacy was absent; there is no WHRN-targeted human clinical trial or approved therapy.
Epidemiology Disease-specific prevalence, incidence, carrier frequency, sex ratio and geographic distribution have not been robustly estimated; WHRN appears to account for only a very small fraction of genetically diagnosed recessive hearing loss. Rare-family reports and heterogeneous sequencing cohorts Orphan disease label; epidemiology terms without disease-specific numerical identifiers Major evidence gap: do not substitute prevalence estimates for all congenital hearing loss, all ARNSHL or Usher syndrome as DFNB31-specific statistics.

Table: Knowledge-base-ready summary of established WHRN-related DFNB31 findings, ontology mappings, evidence types, and major uncertainties. It separates isolated hearing loss from USH2D and morphological AAV8 rescue from functional hearing recovery.

1. Disease information

Definition and classification

DFNB31 denotes autosomal-recessive nonsyndromic hearing loss 31: an inherited cochlear sensorineural hearing impairment caused by pathogenic variation on both WHRN alleles. “Nonsyndromic” means that hearing loss is the defining clinical manifestation; in particular, retinal degeneration is absent during the observed course. Canonical descriptions emphasize profound sensorineural hearing loss with normal vision. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN, mathur2019ushersyndromeand pages 2-3)

This entry should be kept distinct from USH2D, also caused by biallelic WHRN variants, because USH2D combines moderate-to-severe hearing impairment with progressive retinitis pigmentosa/rod–cone dystrophy. Long-term ophthalmic observation may nevertheless be necessary before confidently calling a young patient nonsyndromic. (mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 2-2, mathur2019ushersyndromeand pages 2-3)

Identifiers and synonyms

  • MONDO: MONDO:0011767, autosomal recessive nonsyndromic hearing loss 31.
  • OMIM phenotype: DFNB31; commonly represented as deafness, autosomal recessive 31. The cited molecular study identifies the WHRN/DFNB31 gene entry as OMIM 607084 and USH2D as OMIM 611383. (mathur2015distinctexpressionand pages 2-2)
  • Gene: WHRN; historical gene names include DFNB31 and, in mice, Whrn/Dfnb31.
  • Synonyms: DFNB31; autosomal recessive nonsyndromic deafness 31; nonsyndromic recessive deafness due to WHRN; whirlin-related nonsyndromic hearing loss.
  • ICD-10/ICD-11: no WHRN- or DFNB31-specific billing code was identified. Use the applicable code for bilateral congenital/hereditary sensorineural hearing loss.
  • MeSH: Hearing Loss, Sensorineural; Hearing Loss, Hereditary.
  • Data provenance: this report describes an aggregated disease entity, derived from pedigrees, case series, curated gene–disease resources, and model systems—not individual EHR data.

2. Etiology, risks, protective factors, and environment

Primary cause

The necessary initiating cause is generally a biallelic germline WHRN pathogenic genotype, usually involving loss-of-function alleles such as nonsense, frameshift, or splice-disrupting variants. C-terminal truncating alleles reported in DFNB31 include p.Arg778Ter (R778X) and p.Gly808AspfsTer11 (G808DfsX11). (mathur2015distinctexpressionand pages 10-11, mathur2019ushersyndromeand pages 2-3)

Genetic risk

  • Two carrier parents have, for each pregnancy, the standard autosomal-recessive probabilities: 25% affected, 50% heterozygous carrier, and 25% inheriting neither familial pathogenic allele.
  • Consanguinity increases the probability that both parents carry the same rare allele; several recessive hearing-loss discoveries have arisen through consanguineous families.
  • Mutation position and isoform disruption influence expression: premature termination in the N-terminal portion more often disrupts full-length whirlin in ear and retina and produces USH2D, whereas C-terminal termination may preserve a retinal N-terminal product and produce DFNB31. This is a probabilistic—not deterministic—correlation. (mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 2-2, mathur2015distinctexpressionand pages 10-11)
  • No validated human modifier gene, protective WHRN allele, anticipation mechanism, or quantified germline-mosaicism rate was identified.

Environmental and lifestyle factors

No toxin, infection, diet, occupation, smoking exposure, or lifestyle behavior causes Mendelian DFNB31 in the absence of the causal genotype. Noise, aminoglycosides, platinum drugs, and other ototoxic exposures could impose additional acquired cochlear injury, but a WHRN-specific gene–environment interaction has not been demonstrated. Avoidance of hazardous noise and unnecessary ototoxic medication is therefore prudent tertiary prevention, not primary prevention of the genetic disorder.

No disease-specific metabolic, immune, inflammatory, infectious, or epigenetic trigger is established. Vaccination, antimicrobial prophylaxis, dietary supplementation, and immune therapy have no DFNB31-specific preventive role.

3. Phenotypes

Core phenotype

Manifestation Characteristics Suggested HPO terms
Sensorineural hearing impairment Usually bilateral, congenital/prelingual, severe-to-profound; canonical DFNB31 reports emphasize profound loss Sensorineural hearing impairment; Bilateral sensorineural hearing impairment; Congenital hearing impairment; Profound hearing impairment
Speech/language consequences Delayed spoken-language acquisition or absent speech when early auditory/communication access is inadequate Delayed speech and language development; Absent speech
Normal retinal function Expected in canonical isolated DFNB31, but age and allele location affect confidence Absence of retinitis pigmentosa; normal electroretinogram, where documented
Possible vestibular dysfunction Not adequately quantified in humans; predicted from mouse models, especially where both long and short isoforms are affected Vestibular dysfunction; Abnormality of balance; Delayed gross motor development

Human reports are too few and heterogeneous for reliable phenotype percentages. Published synthesis characterizes DFNB31 as profound sensorineural hearing loss with normal vision, whereas USH2D tends toward moderate hearing loss with retinitis pigmentosa. (mathur2019ushersyndromeand pages 2-3)

A WHRN N-terminal frameshift, p.Pro246HisfsTer13, illustrates that subjective history may underestimate auditory abnormalities: a reported patient considered hearing normal, but formal testing detected an abnormality. This also cautions against assigning phenotype solely from patient report. (mathur2015distinctexpressionand pages 12-13)

Quality of life

There are no validated DFNB31-specific EQ-5D, SF-36, PROMIS, or hearing-related quality-of-life datasets. Expected morbidity arises from impaired speech perception, communication, education, social participation, safety awareness, and occupational function. Early access to spoken language and/or sign language is therefore a central outcome rather than an ancillary intervention.

4. Genetic and molecular information

Gene and protein

  • Gene: WHRN; chromosome 9q32–q34; Ensembl ENSG00000095397. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN, souissi2021novelpathogenicmutations pages 11-12)
  • Protein: whirlin, a cytoskeletal scaffold rather than an enzyme or ion channel.
  • Architecture: full-length whirlin contains three PDZ domains and a proline-rich region; C-terminal whirlin retains the proline-rich region and PDZ3, while N-terminal products contain PDZ1, PDZ2, or both. (mathur2015distinctexpressionand pages 2-2, mathur2019ushersyndromeand pages 2-3)
  • Major interactors: MYO15A and EPS8 at stereociliary tips; USH2A/usherin, ADGRV1/GPR98 and PDZD7 at the ankle-link/base complex. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 12-13)

Variant interpretation

Variants must be normalized against a specified MANE/RefSeq transcript because historical reports use different isoforms and legacy nomenclature. Classification should follow ACMG/AMP hearing-loss specifications and incorporate population frequency, predicted loss of function, segregation, phenotype, transcript relevance, and functional evidence. A variant should not be called pathogenic merely because it is rare or computationally damaging.

The established mechanism is predominantly loss of function. Germline origin is expected. Somatic WHRN variation is not relevant to inherited DFNB31. Large deletions or other copy-number changes are plausible and should be detectable by panel/WES/WGS CNV analysis, but recurrent aneuploidies, translocations, inversions, repeat expansions, or mitochondrial lesions are not characteristic.

Population allele frequencies must be retrieved for each exact variant from the current gnomAD release; no single global carrier frequency can be responsibly assigned. The recent c.74dup USH2D allele was absent from gnomAD, but that case concerns syndromic disease and does not establish a DFNB31 founder allele. (terrasa2026ushersyndrometype pages 4-5, terrasa2026ushersyndrometype pages 2-4)

Epigenetics and profiling

No reproducible disease-specific DNA-methylation, histone, metabolomic, lipidomic, circulating-protein, or immune signature is established. Existing transcript/protein work is primarily tissue localization and isoform analysis in mice. No validated single-cell, spatial-transcriptomic, or multi-omic diagnostic classifier for DFNB31 was identified.

5. Environmental information

DFNB31 is not an environmentally acquired or infectious disorder. Environmental history remains relevant to exclude mixed etiologies and prevent additional hearing damage. Clinicians should document perinatal infection, meningitis, neonatal intensive-care exposures, head trauma, noise, and ototoxic drugs, but none substitutes for molecular confirmation of WHRN-related disease.

6. Mechanism and pathophysiology

Ordered causal chain

  1. Biallelic pathogenic WHRN variation leads to absent, truncated, unstable, or mislocalized whirlin isoforms.
  2. Loss of functional tip-localized whirlin leads to impaired assembly/retention of the MYO15A–WHRN–EPS8 stereociliary elongation complex. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 12-13)
  3. Complex disruption leads to deficient actin-dependent elongation and organization of cochlear hair-cell stereocilia.
  4. Short, dysmorphic stereociliary bundles lead to abnormal coupling of sound-induced bundle displacement to mechanotransduction; this human step is inferred from conserved hair-cell biology and demonstrated mouse morphology.
  5. Defective hair-cell mechanosensation leads to bilateral sensorineural hearing loss and, with prolonged dysfunction, hair-cell vulnerability/loss. AAV rescue increased inner-hair-cell survival, supporting this downstream relationship. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9)
  6. Retinal branch: N-terminal lesions disrupting full-length whirlin lead to failure of the USH2/periciliary complex in photoreceptors and progressive retinal degeneration—USH2D rather than isolated DFNB31. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2)
  7. Retinal-sparing branch: C-terminal lesions that preserve a partially functional N-terminal retinal product can result in normal retinal function but profound deafness—canonical DFNB31. (mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 10-11)
  8. Vestibular branch: loss of relevant isoforms in vestibular hair cells leads to abnormal vestibular stereociliary growth and severe vestibular deficits in mice; clinically important human vestibular involvement remains inferred and insufficiently measured. (mathur2015astudyof pages 1-2)

Upstream and downstream biology

The upstream lesion is transcript/protein loss of function. The central cellular process is actin-rich stereocilium development and maintenance, not canonical Wnt, MAPK, mTOR, or PI3K–AKT signaling. Downstream events are impaired mechanotransduction, sensory-cell dysfunction, and possible degeneration. There is no evidence that systemic metabolism, autoimmunity, fibrosis, ischemia, or inflammation is primary.

Suggested GO biological-process terms: stereocilium organization; actin filament organization; sensory perception of sound; inner-ear receptor-cell differentiation; detection of mechanical stimulus involved in sensory perception of sound.

Suggested GO cellular-component terms: stereocilium; stereocilium tip; hair-cell stereociliary bundle; actin cytoskeleton; protein-containing complex; photoreceptor connecting cilium/periciliary membrane complex for the USH2D branch.

Suggested Cell Ontology labels: inner hair cell; outer hair cell; vestibular hair cell; retinal rod photoreceptor cell; retinal cone photoreceptor cell.

7. Anatomical structures affected

The principal organ is the inner ear, especially the cochlea and organ of Corti. Both inner- and outer-hair-cell stereociliary bundles are implicated. Full-length and C-terminal whirlin localize at inner-hair-cell stereociliary tips, while developing outer-hair-cell tips primarily contain C-terminal whirlin; full-length whirlin also transiently participates at stereociliary bases/ankle links. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 12-13)

Vestibular sensory epithelia are a plausible secondary site. Mouse vestibular organs express full-length and C-terminal whirlin; loss produces abnormal stereocilia and electrophysiologic balance deficits. (mathur2015astudyof pages 1-2)

The retina is not clinically affected in canonical DFNB31, but photoreceptor periciliary structures are affected in WHRN-related USH2D. This distinction is central to diagnosis rather than evidence that every WHRN genotype is syndromic. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2)

Suggested anatomy labels include UBERON: inner ear, cochlea, organ of Corti, vestibular organ, retina, and photoreceptor layer. Hearing loss is expected to be bilateral; consistent unilateral WHRN disease would warrant investigation for another or additional cause.

8. Temporal development

Onset is usually congenital or prelingual and the disease is lifelong. Reliable DFNB31-specific longitudinal progression rates and formal clinical stages are unavailable. Unlike inflammatory or relapsing disorders, it is not episodic and spontaneous remission is not expected.

The most important intervention period is infancy and early childhood, when auditory access and language exposure shape neurodevelopment. Preclinical WHRN data also indicate a narrow biological window: neonatal treatment restored morphology, whereas adult AAV8-whirlin treatment did not recover stereociliary length or row number. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9)

9. Inheritance and population

Inheritance is autosomal recessive, with affected males and females expected in equal proportions. Penetrance appears high for clearly deleterious biallelic alleles causing profound congenital loss, but no robust numerical penetrance estimate exists. Expressivity can vary with allele position and isoform disruption. Anticipation is not expected.

No defensible DFNB31-specific prevalence, incidence, sex ratio, global carrier frequency, or number of living affected individuals is available. WHRN diagnoses have been reported across multiple ancestries, including families from South Asia, Türkiye, North Africa, and Europe, but these reports do not establish population prevalence. Consanguinity facilitates homozygosity for rare alleles. Disease-specific founder effects should be asserted only for a documented variant and population.

Statistics for all congenital hearing loss, autosomal-recessive nonsyndromic hearing loss, or Usher syndrome must not be relabeled as DFNB31 statistics. This is a major evidence gap.

10. Diagnostics

Clinical evaluation

  1. Confirm hearing phenotype: newborn otoacoustic-emission and/or automated ABR screening followed by diagnostic frequency-specific ABR; tympanometry; otoacoustic emissions; age-appropriate behavioral audiometry; later pure-tone and speech audiometry.
  2. Establish type: air- and bone-conduction testing should demonstrate sensorineural rather than conductive loss.
  3. Assess functional needs: aided speech perception, auditory development, communication milestones, and hearing-aid benefit.
  4. Evaluate syndromic mimics: ophthalmic history/examination and, depending on genotype, age, or symptoms, OCT, fundus autofluorescence and electroretinography. Vestibular testing is appropriate for imbalance, delayed walking, oscillopsia, or abnormal motor development. The recent USH2D case demonstrates the utility of OCT, ERG and EOG for retinal characterization. (terrasa2026ushersyndrometype pages 4-5, terrasa2026ushersyndrometype pages 2-4)
  5. Imaging: temporal-bone CT or MRI may be used for cochlear-implant planning or suspected anatomic/nerve abnormality, but no WHRN-specific radiologic lesion is expected.
  6. Biopsy/laboratory biomarkers: no blood chemistry, enzyme assay, histopathology, liquid biopsy, or validated molecular biomarker diagnoses DFNB31.

Genetic testing strategy

A comprehensive hearing-loss NGS panel that includes WHRN and syndromic hearing-loss genes, with exon-level deletion/duplication analysis, is generally the most efficient first molecular test. Test parental samples for phase and segregation. WES or WGS is appropriate when panel testing is negative, when structural/noncoding variation is suspected, or when phenotype is atypical. Targeted Sanger sequencing is useful for confirming and cascading a known familial variant, not for comprehensively screening this heterogeneous condition.

CMA, karyotyping and FISH are low-yield unless developmental anomalies suggest a chromosomal disorder. Mitochondrial sequencing and repeat-expansion assays are not WHRN tests but may be used in a broader differential.

Differential diagnosis

The principal molecular differential includes numerous causes of congenital AR nonsyndromic hearing loss, particularly GJB2, STRC, OTOF, MYO15A, EPS8, TMC1, TMIE, LOXHD1, CDH23, PCDH15, MYO7A, USH1C, USH1G, USH2A, ADGRV1, and PDZD7. The critical phenotypic differential is evolving Usher syndrome. Congenital CMV, anatomic inner-ear abnormalities, auditory neuropathy, meningitis, and ototoxic injury should be considered based on history and testing.

Screening

Universal newborn hearing screening can detect congenital profound DFNB31 but cannot specify the gene. Once familial variants are known, cascade carrier testing, prenatal diagnosis, and preimplantation genetic testing are technically feasible after nondirective counseling.

11. Outcome and prognosis

DFNB31 does not appear to shorten life expectancy, and no disease-specific mortality is known. Morbidity is predominantly communication and hearing-related. Hearing does not spontaneously recover because mammalian cochlear sensory hair cells and their specialized stereociliary architecture do not naturally regenerate sufficiently.

Prognosis for language and participation depends more on age at detection, communication access, intervention, aided hearing, educational support, and cochlear-implant candidacy than on a validated WHRN biomarker. Normal retinal surveillance substantially improves confidence that prognosis is nonsyndromic; development of rod–cone dysfunction changes the diagnosis and counseling to USH2D.

No DFNB31-specific cochlear-implant response rate, survival curve, validated prognostic model, or quality-of-life effect size was found.

12. Treatment

Current care

There is no approved WHRN-directed drug, pharmacogenomic recommendation, cell therapy, RNA therapy, or genome-editing treatment.

  • Hearing aids: appropriate when residual hearing and aided speech access are adequate. Suggested NCIT label: Hearing Aid.
  • Cochlear implantation: evaluate severe-to-profound bilateral loss with inadequate hearing-aid benefit. Suggested NCIT labels: Cochlear Implant; Cochlear Implantation.
  • Communication and rehabilitation: early speech-language therapy, auditory habilitation, educational accommodations, family-centered communication planning, and access to sign language according to family/patient goals. Suggested NCIT labels: Speech Therapy; Rehabilitation Therapy.
  • Vestibular rehabilitation: consider when objective or symptomatic balance dysfunction is present.

Experimental gene therapy

Chien and colleagues injected approximately 1 × 10^13 genome copies/mL AAV8 carrying the 2,724-bp long Whrn cDNA under a CMV promoter through the round window of whirler mice at postnatal days P1–P5. Animals were assessed through P90, including ABRs at 4, 8, 16 and 32 kHz. Whirlin expression, normal stereociliary length/bundle architecture, and inner-hair-cell survival improved. (chien2016genetherapyrestores pages 8-9)

The abstract’s key claim was that “normal stereocilia length and bundle architecture were restored” and that therapy “increased inner hair cell survival.” Nevertheless, the subsequent evidence synthesis found no improvement in hearing sensitivity at any tested ABR frequency. Infection predominantly involved inner hair cells, likely limiting whole-cochlea rescue. Adult administration did not recover stereociliary length or row number. Thus this is target-engagement and morphological proof of concept, not functional cure. (chien2016genetherapyrestores pages 9-9, brotto2024autosomalrecessivenonsyndromic pages 2-3)

The 2024 review of AR nonsyndromic-deafness AAV programs identified 17 preclinical and three clinical studies overall, but excluded WHRN from functionally successful programs because hearing was not restored. No WHRN/DFNB31-specific NCT study was identified in the ClinicalTrials.gov search. (brotto2024autosomalrecessivenonsyndromic pages 2-3)

13. Prevention

The mutation cannot be prevented by lifestyle change.

  • Primary/reproductive prevention: genetic counseling, partner testing where appropriate, cascade testing, prenatal diagnosis, or PGT-M after familial variants are established.
  • Secondary prevention: universal newborn hearing screening, rapid diagnostic audiology, molecular diagnosis, and early communication intervention.
  • Tertiary prevention: protect residual hearing from hazardous noise and avoid unnecessary ototoxic exposure; optimize hearing devices, education and rehabilitation; monitor vision when genotype or symptoms could indicate USH2D.
  • Vaccination and antimicrobial prophylaxis have no WHRN-specific role, although routine vaccination can prevent some acquired causes of hearing loss.

14. Other species and natural disease

Mus musculus (NCBI Taxon 10090) has the ortholog Whrn and provides the principal comparative system. The naturally occurring whirler (Whrnwi/wi) mutant has profound deafness, short/dysmorphic stereocilia and overt vestibular behavior. Engineered Dfnb31neo/neo mice retain C-terminal whirlin, show hearing loss and later retinal degeneration, whereas wi/wi animals retain a truncated N-terminal retinal product and do not show comparable retinal degeneration. These allele-specific phenotypes closely model the DFNB31–USH2D isoform distinction. (mathur2015distinctexpressionand pages 1-2, mathur2015distinctexpressionand pages 2-2, mathur2015astudyof pages 1-2)

In vestibular studies, wi/wi mice displayed circling, head bobbing, severe-to-profound vestibular sensory-evoked-potential deficits, and greater balance impairment than neo/neo mice; neo/neo animals lacked an obvious balance phenotype despite objective deficits. (mathur2015astudyof pages 1-2)

No established naturally occurring veterinary syndrome in a named domestic breed, VBO breed mapping, or zoonotic transmission was identified. DFNB31 is genetic and noncommunicable.

15. Model organisms and experimental systems

Available models

  • Whrnwi/wi whirler mouse: naturally occurring recessive mutant; strong deafness and vestibular phenotype; useful for stereocilia biology and cochlear delivery studies.
  • Dfnb31neo/neo mouse: engineered allele preferentially affecting long/full-length products; models combined auditory/retinal disease and retained C-terminal whirlin.
  • Additional transcript-specific engineered mice have been used to resolve N-, C-, and full-length isoform functions.
  • Hair-cell explants, immunolocalization, confocal microscopy and scanning electron microscopy serve as ex vivo/cellular systems.

Strengths and limitations

Mouse models reproduce stereociliary shortening, hair-bundle disorganization, hearing dysfunction, vestibular abnormalities, and allele-dependent retinal involvement. They enable direct structural study that is impossible in living human cochleae. Limitations include species-specific cochlear maturation, vector tropism, delivery scale, and imperfect correspondence between mouse alleles and every human transcript. Most importantly, restored morphology did not translate into restored ABR thresholds in the AAV8 experiment. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9, brotto2024autosomalrecessivenonsyndromic pages 2-3)

Recent developments and expert assessment

The most directly relevant 2023 report identified a novel pathogenic WHRN variant in a Moroccan family, extending the allelic spectrum, although accessible evidence did not provide sufficiently detailed variant-level findings to reproduce here safely. Recent 2024 reviews emphasize rapid progress in AAV treatment of recessive hearing loss generally, while classifying WHRN supplementation as morphologically promising but functionally unsuccessful to date. This distinction is essential: the WHRN program has not yet met the translational benchmark of hearing restoration. (brotto2024autosomalrecessivenonsyndromic pages 2-3)

The present expert interpretation is therefore:

  1. Gene–disease validity is strong: biallelic WHRN loss is established for DFNB31. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN)
  2. Mechanistic validity is strong in models: whirlin is a stereociliary scaffold required for normal bundle elongation and organization. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2)
  3. Genotype–phenotype prediction is useful but imperfect: C-terminal retinal-sparing versus N-terminal USH2D is a guiding framework, not a substitute for longitudinal retinal assessment. (mathur2015distinctexpressionand pages 2-2, mathur2015distinctexpressionand pages 10-11, mathur2019ushersyndromeand pages 2-3)
  4. Clinical evidence remains sparse: disease-specific prevalence, penetrance, natural history, treatment-response rates and quality-of-life statistics are unavailable.
  5. Therapeutic readiness is preclinical: improved vector tropism, broader outer-hair-cell delivery, correct isoform selection, and very early administration may be required before WHRN therapy can restore hearing.

Key publications and URLs

  • Mburu et al. “Defects in whirlin…cause deafness in the whirler mouse and families with DFNB31.” Nature Genetics 34:421–428, August 2003. DOI: https://doi.org/10.1038/ng1208. Foundational human/mouse gene-discovery study; indexed among the supporting WHRN literature. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN, souissi2021novelpathogenicmutations pages 11-12)
  • Mathur et al. “Distinct expression and function of whirlin isoforms…” Human Molecular Genetics 24:6213–6228, published online 24 August 2015. DOI: https://doi.org/10.1093/hmg/ddv339. (mathur2015distinctexpressionand pages 11-12, mathur2015distinctexpressionand pages 1-2)
  • Mathur et al. “A study of whirlin isoforms in the mouse vestibular system…” Human Molecular Genetics 24:7017–7030, advance publication 29 September 2015. DOI: https://doi.org/10.1093/hmg/ddv403. (mathur2015astudyof pages 1-2)
  • Chien et al. “Gene Therapy Restores Hair Cell Stereocilia Morphology…” Molecular Therapy 24:17–25, January 2016. DOI: https://doi.org/10.1038/mt.2015.150. (chien2016genetherapyrestores pages 9-9, chien2016genetherapyrestores pages 8-9)
  • Mathur & Yang. “Usher syndrome and non-syndromic deafness: Functions of different whirlin isoforms…” Hearing Research 375:14–24, April 2019. DOI: https://doi.org/10.1016/j.heares.2019.02.007. (mathur2019ushersyndromeand pages 2-3)
  • AitRaise et al. “Novel pathogenic WHRN variant causing hearing loss in a Moroccan family.” Molecular Biology Reports 50:10663–10669, November 2023. DOI: https://doi.org/10.1007/s11033-023-08901-8.
  • Brotto et al. “Autosomal Recessive Non-Syndromic Deafness: Is AAV Gene Therapy a Real Chance?” Audiology Research 14:239–253, February 2024. DOI: https://doi.org/10.3390/audiolres14020022. (brotto2024autosomalrecessivenonsyndromic pages 2-3)

Evidence caveat: PMID values were not consistently exposed in the retrieved full texts, so DOI URLs are given rather than guessing identifiers. Direct quotations were limited to text verifiably present in retrieved abstracts. Assertions lacking DFNB31-specific data have been explicitly labeled unavailable, inferred from models, or extrapolated from standard congenital sensorineural-hearing-loss practice.

References

  1. (OpenTargets Search: autosomal recessive nonsyndromic hearing loss-WHRN): Open Targets Query (autosomal recessive nonsyndromic hearing loss-WHRN, 13 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  2. (mathur2019ushersyndromeand pages 2-3): Pranav Dinesh Mathur and Jun Yang. Usher syndrome and non-syndromic deafness: functions of different whirlin isoforms in the cochlea, vestibular organs, and retina. Hearing Research, 375:14-24, Apr 2019. URL: https://doi.org/10.1016/j.heares.2019.02.007, doi:10.1016/j.heares.2019.02.007. This article has 75 citations and is from a domain leading peer-reviewed journal.

  3. (mathur2015distinctexpressionand pages 11-12): Pranav Dinesh Mathur, Junhuang Zou, Tihua Zheng, Ali Almishaal, Yong Wang, Qian Chen, Le Wang, Deepti Vashist, Steve Brown, Albert Park, and Jun Yang. Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of ush2d and dfnb31. Human molecular genetics, 24 21:6213-28, Aug 2015. URL: https://doi.org/10.1093/hmg/ddv339, doi:10.1093/hmg/ddv339. This article has 43 citations and is from a domain leading peer-reviewed journal.

  4. (mathur2015distinctexpressionand pages 1-2): Pranav Dinesh Mathur, Junhuang Zou, Tihua Zheng, Ali Almishaal, Yong Wang, Qian Chen, Le Wang, Deepti Vashist, Steve Brown, Albert Park, and Jun Yang. Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of ush2d and dfnb31. Human molecular genetics, 24 21:6213-28, Aug 2015. URL: https://doi.org/10.1093/hmg/ddv339, doi:10.1093/hmg/ddv339. This article has 43 citations and is from a domain leading peer-reviewed journal.

  5. (mathur2015distinctexpressionand pages 12-13): Pranav Dinesh Mathur, Junhuang Zou, Tihua Zheng, Ali Almishaal, Yong Wang, Qian Chen, Le Wang, Deepti Vashist, Steve Brown, Albert Park, and Jun Yang. Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of ush2d and dfnb31. Human molecular genetics, 24 21:6213-28, Aug 2015. URL: https://doi.org/10.1093/hmg/ddv339, doi:10.1093/hmg/ddv339. This article has 43 citations and is from a domain leading peer-reviewed journal.

  6. (chien2016genetherapyrestores pages 9-9): Wade W Chien, Kevin Isgrig, Soumen Roy, Inna A Belyantseva, Meghan C Drummond, Lindsey A May, Tracy S Fitzgerald, Thomas B Friedman, and Lisa L Cunningham. Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice. Molecular therapy : the journal of the American Society of Gene Therapy, 24 1:17-25, Jan 2016. URL: https://doi.org/10.1038/mt.2015.150, doi:10.1038/mt.2015.150. This article has 120 citations.

  7. (chien2016genetherapyrestores pages 8-9): Wade W Chien, Kevin Isgrig, Soumen Roy, Inna A Belyantseva, Meghan C Drummond, Lindsey A May, Tracy S Fitzgerald, Thomas B Friedman, and Lisa L Cunningham. Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice. Molecular therapy : the journal of the American Society of Gene Therapy, 24 1:17-25, Jan 2016. URL: https://doi.org/10.1038/mt.2015.150, doi:10.1038/mt.2015.150. This article has 120 citations.

  8. (brotto2024autosomalrecessivenonsyndromic pages 2-3): Davide Brotto, Marco Greggio, Cosimo De Filippis, and Patrizia Trevisi. Autosomal recessive non-syndromic deafness: is aav gene therapy a real chance? Audiology Research, 14:239-253, Feb 2024. URL: https://doi.org/10.3390/audiolres14020022, doi:10.3390/audiolres14020022. This article has 8 citations.

  9. (mathur2015distinctexpressionand pages 2-2): Pranav Dinesh Mathur, Junhuang Zou, Tihua Zheng, Ali Almishaal, Yong Wang, Qian Chen, Le Wang, Deepti Vashist, Steve Brown, Albert Park, and Jun Yang. Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of ush2d and dfnb31. Human molecular genetics, 24 21:6213-28, Aug 2015. URL: https://doi.org/10.1093/hmg/ddv339, doi:10.1093/hmg/ddv339. This article has 43 citations and is from a domain leading peer-reviewed journal.

  10. (souissi2021novelpathogenicmutations pages 11-12): Amal Souissi, Mariem Ben Said, Ikhlas Ben Ayed, Ines Elloumi, Amal Bouzid, Mohamed Ali Mosrati, Mehdi Hasnaoui, Malek Belcadhi, Nabil Idriss, Hassen Kamoun, Nourhene Gharbi, Abdullah A. Gibriel, Abdelaziz Tlili, and Saber Masmoudi. Novel pathogenic mutations and further evidence for clinical relevance of genes and variants causing hearing impairment in tunisian population. Jul 2021. URL: https://doi.org/10.1016/j.jare.2021.01.005, doi:10.1016/j.jare.2021.01.005. This article has 27 citations and is from a peer-reviewed journal.

  11. (mathur2015astudyof pages 1-2): Pranav Dinesh Mathur, Sarath Vijayakumar, Deepti Vashist, Sherri M. Jones, Timothy A. Jones, and Jun Yang. A study of whirlin isoforms in the mouse vestibular system suggests potential vestibular dysfunction in dfnb31-deficient patients. Human molecular genetics, 24 24:7017-30, Dec 2015. URL: https://doi.org/10.1093/hmg/ddv403, doi:10.1093/hmg/ddv403. This article has 21 citations and is from a domain leading peer-reviewed journal.

  12. (mathur2015distinctexpressionand pages 10-11): Pranav Dinesh Mathur, Junhuang Zou, Tihua Zheng, Ali Almishaal, Yong Wang, Qian Chen, Le Wang, Deepti Vashist, Steve Brown, Albert Park, and Jun Yang. Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of ush2d and dfnb31. Human molecular genetics, 24 21:6213-28, Aug 2015. URL: https://doi.org/10.1093/hmg/ddv339, doi:10.1093/hmg/ddv339. This article has 43 citations and is from a domain leading peer-reviewed journal.

  13. (terrasa2026ushersyndrometype pages 2-4): Emilio A Cepeda Terrasa, Adriana Ramirez, and Natalio Izquierdo. Usher syndrome type 2d associated with a novel homozygous whrn c.74dup variant: a case report. Jun 2026. URL: https://doi.org/10.7759/cureus.110478, doi:10.7759/cureus.110478. This article has 0 citations.

  14. (terrasa2026ushersyndrometype pages 4-5): Emilio A Cepeda Terrasa, Adriana Ramirez, and Natalio Izquierdo. Usher syndrome type 2d associated with a novel homozygous whrn c.74dup variant: a case report. Jun 2026. URL: https://doi.org/10.7759/cureus.110478, doi:10.7759/cureus.110478. This article has 0 citations.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 9
Resolved 9
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 9
On topic 1
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 1
Resolved 1
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 0
Terms whose name was checked 1
Terms named correctly 0
Terms named as a different term 1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0011767 (4 mentions) - the report calls it "if available"; MONDO calls it autosomal recessive nonsyndromic hearing loss 31